Next Article in Journal
Oral Delivery of Liraglutide Formulated with PLGA for Sustained Obesity Management
Previous Article in Journal
Development and Validation of an Ion-Pair Reverse-Phase High-Performance Liquid Chromatography–Electrospray Ionization Mass Spectrometry Method for Determination of Purity of Nusinersen for Quality Control of Drug Substance or Drug Product
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities

Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2026, 27(7), 3302; https://doi.org/10.3390/ijms27073302
Submission received: 14 March 2026 / Revised: 28 March 2026 / Accepted: 30 March 2026 / Published: 5 April 2026

Abstract

Molecular docking is a foundational technique in computational drug discovery, widely used to generate binding hypotheses, prioritize compounds, and support target-selectivity studies. The continued growth of open-source docking resources, together with improvements in scoring functions, sampling strategies, and hardware acceleration, has substantially lowered barriers to teaching, early-stage hit identification, and reproducible research. Beyond standalone docking engines, the open-source ecosystem now encompasses browser-accessible tools, preparation and analysis utilities, integrative modeling platforms, and AI-augmented methods for pose prediction, rescoring, and virtual screening. These developments have made docking workflows more accessible, customizable, and transparent across diverse research settings. This review examines open-source docking from a workflow-centered perspective, spanning study design, structural-data acquisition, binding-site definition, receptor and ligand preparation, docking execution, and post-docking validation. It further evaluates how open AI methods are being incorporated into these stages to expand structural coverage, improve screening efficiency, and support contemporary structure-based drug design. Collectively, this review outlines a practical and evidence-based framework for the effective use of open-source docking and virtual-screening pipelines in modern drug discovery.

1. Introduction

The field of Structure-Based Drug Design (SBDD) has made significant strides in the last twenty years, propelled by advancements in computational techniques and the swift growth of publicly available structural resources [1,2]. In particular, the Protein Data Bank (PDB) and the wider structural data ecosystem have facilitated access to experimentally determined macromolecular structures and numerous protein–ligand complexes, thereby aiding hypothesis-driven hit finding and lead optimization in academia and industry [3,4]. Simultaneously, the ability to simulate molecular interactions and predict binding affinities, once limited to pharmaceutical companies using costly proprietary software, has become accessible due to the rise in open-source and free academic tools, thereby reducing barriers to entry for structure-based workflows [5,6,7]. A key component of this evolution is molecular docking, a computational technique employed to predict the optimal orientation of one molecule relative to another when they interact to form a stable complex [8,9,10,11]. Figure 1 provides an overview of commonly used docking approaches and their applications. The main goal of molecular docking is to model the atomic interactions between a small molecule or ligand and a macromolecular target or receptor, predicting the binding conformation and the strength of the association in terms of affinity or score [12,13,14]. This process facilitates virtual screening (VS) of extensive chemical libraries, enabling researchers to prioritize a feasible number of compounds for experimental validation from a pool of millions or billions of candidates [15,16]. Traditional computational drug discovery has been influenced by the classical “lock-and-key” model, in which stochastic search algorithms and empirical scoring functions are used to estimate small-molecule binding [17].
The widespread use of docking in academic laboratories has been greatly facilitated by the availability of effective, open-source engines like AutoDock Vina, which offer improved throughput and usability compared to previous docking software generations [18,19]. Accessibility has been enhanced through web-based platforms that eliminate the need for installation and parameterization, offering standardized interfaces for docking jobs. Examples include SwissDock and blind-docking servers like CB-Dock2 [5,20,21]. The focus within the community has progressively transitioned from solely providing software access to prioritizing the quality of protocols, validation, and reproducible execution in diverse computing environments [22].
Recent advancements in AI technologies have begun to revolutionize traditional SBDD workflows at various stages, such as pose prediction, rescoring, and complex structure prediction [23]. AI co-folding and complex-prediction foundational models that deduce protein–ligand complex structures from sequence and ligand representations are of particular interest [24]. Notable examples are Uni-Mol (pose prediction and 3D molecular representation learning) [25], Umol (sequence-to-complex prediction) [26], Boltz-2 (complex prediction with affinity-oriented objectives) [27], and Chai-1 (multimodal biomolecular structure prediction) [28]. These approaches can produce high-quality initial geometries for subsequent modeling; however, current evidence indicates that they should be regarded as complementary to, rather than substitutes for, physics-based affinity estimation, especially when quantitative ranking is necessary [23,29]. Rigorous free-energy methods, such as alchemical approaches, can achieve high accuracy in certain contexts; however, they are relatively resource-intensive and consequently less prevalent in the initial screening phases [30,31,32,33].
The need for scalable and effective screening has intensified with the rapid growth of the make-on-demand chemical sector. Enamine REAL Space contains tens of billions of synthetically accessible compounds, highlighting how rapidly enumerated libraries can surpass the throughput of traditional single-workstation workflows [34,35]. As libraries expand to multi-billion scales, SBDD presents a significant data-engineering challenge alongside modeling challenges. This necessitates efficient storage formats and query tools, such as Parquet and DuckDB, to facilitate filtering, featurization, and orchestration in large-scale virtual screening pipelines [36]. These developments collectively offer a unified perspective on modern computer-assisted drug design and discovery that integrates open-source resources such as docking tools, accessible web services, specialized protocols, and emerging AI models into a coherent framework. Accordingly, this review aims to map the ecosystem that underpins these workflows.

2. Why Free Docking Tools and Resources Matter

The significance of free and open-source docking resources extends far beyond simple cost reduction; rather, it reflects a broader transition toward a scientific ecosystem that is more transparent, reproducible, and inclusive. Historically, computational chemistry and molecular modeling have been strongly influenced by proprietary software environments that require expensive licenses [37,38,39]. While such platforms have contributed significantly to the development of molecular modeling methodologies, their cost and restricted accessibility have often limited widespread academic adoption and hindered interoperability between research groups. In addition, the closed architecture of proprietary software can restrict researchers’ ability to inspect or modify the algorithms and parameterizations underlying computational predictions, thereby complicating transparent benchmarking and independent validation. The increasing availability of open docking frameworks and open data resources has therefore played an important role in expanding access to structure-based drug discovery and enabling collaborative methodological development across the global research community [22,40]. A flowchart summarizing the rationale for open-source molecular docking tools is shown in Figure 2.
A significant challenge in computational chemistry is the issue of reproducibility. Proprietary software typically operates as a black box, rendering the underlying algorithms and scoring functions unavailable for peer review. Open-source docking platforms address this limitation by offering transparent access to source code and methodological implementations, facilitating independent verification of computational workflows. This transparency enables researchers to assess algorithmic theories, replicate docking outcomes, and systematically compare various docking methodologies. This openness is recognized as crucial for ensuring methodological rigor and promoting the continuous enhancement of docking algorithms utilized in virtual screening and SBDD processes [22].
Moreover, financial accessibility represents a significant factor, highlighting the necessity of open computational tools. The licensing costs of commercial molecular modeling platforms can create significant financial obstacles for numerous academic laboratories, especially in developing regions or institutions with constrained research funding. Free docking software, open chemical databases, and publicly accessible web servers facilitate broader access to structure-based drug discovery technologies. Reducing financial barriers allows an increased number of researchers to engage in computational drug discovery and virtual screening initiatives [41]. This accessibility is especially significant for research focused on neglected or emerging diseases, where drug discovery efforts are frequently led by academic and public-sector laboratories instead of industry [42].
The value of free and openly accessible docking resources is also supported increasingly by prospective rather than purely retrospective evidence. In other words, these tools matter not only because they lower cost and improve transparency, but also because they have already contributed to experimentally validated hit discovery. For example, AlphaFold2-guided large-library docking with DOCK3.8 was used prospectively for ligand discovery against challenging membrane targets and showed that docking to predicted structures could recover hit rates and affinities comparable to those obtained with experimental receptor structures, with some identified ligands reaching low-nanomolar potency [43]. Likewise, the RosettaVS platform, while more accurately described as freely available for academic use rather than strictly open-source, identified prospective hits against KLHDC2 and NaV1.7 with reported hit rates of 14% and 44%, respectively, and the predicted binding mode for a KLHDC2 ligand was subsequently validated crystallographically [44]. Such studies are important because they demonstrate that open or freely accessible docking-centered workflows are no longer only methodological frameworks or teaching tools, but practical discovery engines capable of producing experimentally confirmed ligands when coupled to careful target preparation and downstream validation [43,44,45,46,47,48,49,50,51,52,53]. Few selected prospective success stories from free or academically accessible docking/SBDD workflows are summarized in Table 1.
Open computational infrastructures also play a crucial role in education and training within modern medicinal chemistry and cheminformatics. One of the challenges associated with advanced computer-aided drug design workflows is the steep learning curve required to master specialized computational tools and scripting environments. Educational initiatives based on open-source resources have addressed this limitation by providing accessible training frameworks that integrate theoretical concepts with practical computational exercises. Platforms such as TeachOpenCADD offer modular tutorials and reproducible workflows implemented in Python and interactive notebook environments, enabling students and early-career researchers to execute and modify realistic docking and virtual screening pipelines [54]. These open educational approaches have proven valuable for expanding computational training in medicinal chemistry curricula and for supporting remote or self-directed learning environments [55,56].
Finally, open-source docking tools offer flexibility and adaptability that are difficult to attain in static proprietary environments. The public availability of their source code allows researchers to modify and extend these tools to tackle emerging methodological challenges. Modern open frameworks make it easier to combine docking algorithms with machine-learning scoring functions and automated high-throughput screening workflows. Recent developments, such as modular docking frameworks in contemporary programming environments, demonstrate how open infrastructures facilitate rapid algorithmic innovation and integration with artificial intelligence methodologies [57,58]. Community-driven ecosystems are progressively facilitating large-scale virtual screening, advanced docking methodologies, and collaborative initiatives in the SBDD field [59,60,61].

3. Bibliometric Overview of Open and Commercial Docking Platforms

Citation counts are an imperfect but still informative indicator of the visibility, dissemination, and historical uptake of computational tools within the scientific literature. In the docking and broader SBDD landscape, the present bibliometric snapshot suggests that open and freely accessible platforms have achieved wider representation in academic publishing than commercial alternatives. This pattern is driven most clearly by the exceptional prominence of the AutoDock family, especially AutoDock4 and AutoDock Vina, and is further reinforced by the continued citation visibility of other open tools such as the DOCK family, smina, GNINA, rDock, SwissDock, and related academic platforms. By contrast, commercial programs such as Glide, GOLD, MOE Docking, Discovery Studio/CDOCKER, Surflex-Dock, FlexX, and other proprietary suites remain highly influential and widely used, but their representation in the published literature appears, on the whole, to be less dominant than that of the most established open platforms. At the same time, these citation patterns should not be overinterpreted as evidence of methodological superiority. Citation frequency is shaped by multiple confounding factors, including software age, the prominence and accessibility of the original reference paper, differences in citation habits across disciplines, and the fact that commercial tools may be heavily used in industrial pipelines without generating proportionate citation records in the public literature. Moreover, citation counts do not directly capture docking accuracy, scoring reliability, maintenance activity, workflow integration, user support, or suitability for specific target classes and screening scenarios. Accordingly, Figure 3 should be interpreted primarily as a bibliometric overview of historical visibility and community adoption, not as a ranking of technical performance. Even so, the overall trend remains clear: the academic literature appears to give broader and more sustained visibility to open docking platforms, whereas commercial tools retain strong but comparatively more selective prominence, especially in well-funded academic and industrial settings.

4. Docking Workflow

4.1. Designing the Docking Study

A docking study is most effective when it is designed as a structured decision-making framework that systematically aligns the research objective with the appropriate levels of conformational sampling, scoring, and validation, as outlined in Figure 4. Accordingly, the criteria for success should be defined in relation to the intended application, whether the goal is accurate pose prediction for mechanistic interpretation, early enrichment in virtual screening, or the assessment of selectivity trends across closely related targets. From this perspective, docking performance should not be regarded as an inherent attribute of a particular software platform. Instead, it reflects the combined influence of the search algorithm, scoring function, available experimental knowledge, and the extent to which the protocol has been validated using appropriate positive and negative controls [62,63,64].
In virtual screening, performance assessment should emphasize early recognition rather than global rank correlation because the practical value of a screening campaign lies in placing active compounds near the top of the ranked list. Metrics such as enrichment factor, BEDROC, and related early-recognition measures are therefore often more informative than global ROC-based summaries alone, although each metric has recognized limitations and should be interpreted in the context of dataset composition and decoy design. Benchmark construction is likewise not a minor reporting detail, as unrealistic active/decoy sets and chemically biased benchmarks can substantially overestimate apparent performance. For this reason, the selected metric, dataset design, and validation objective should be reported explicitly as part of methodological rigor [65,66].

4.2. Acquisition of Structural Data and Selection of Biological Assemblies

Whenever possible, structural coordinates should be derived from experimentally determined models deposited in the Protein Data Bank. In the absence of a suitable experimental structure, high-quality predictive models, including those generated by AlphaFold-class methods, may serve as useful alternatives, provided that their limitations are acknowledged. The selected structure should correspond to the biologically relevant assembly rather than merely the asymmetric unit, and it should retain any cofactors, catalytic ions, prosthetic groups, or tightly bound ligands that define the physicochemical environment of the binding site [3,67].
This choice is especially important because the docking target is not simply a protein scaffold, but a chemically specific recognition environment. Binding-site geometry, electrostatics, and accessibility may all change if an incorrect oligomeric state is chosen or if essential metals, cofactors, or bridging water molecules are omitted. These considerations are particularly critical for metalloenzymes and related systems in which coordination geometry contributes directly to molecular recognition and catalysis [68,69]. Key preparation and post-docking analysis tools that support reproducible workflows are summarized in Table 2.

4.3. Binding-Site Definition and Search-Space Setup

The most important practical aspect for small molecules is the knowledge of the binding site. When a co-crystallized ligand, catalytic residues, mutagenesis data, or biochemical restraints are available, they should guide the placement of the box center and the dimensions of the search space. Reporting the coordinates and size of the search region is essential for reproducibility, particularly in comparative studies, where differences in docking outcomes may otherwise reflect inconsistent box definitions rather than meaningful differences between docking engines [70].
This step warrants particular emphasis because the search space directly influences both pose prediction and screening performance. Overly narrow boxes can artificially improve apparent pose recovery by constraining sampling around the expected solution, whereas excessively large boxes reduce efficiency and increase the likelihood of irrelevant placements. Systematic studies using Vina have shown that search-space selection measurably affects both docking accuracy and enrichment [18]. In cases where the pocket is unidentified, employing a global strategy, such as blind docking or pocket discovery followed by focused docking, is suitable for generating hypotheses [71,72,73,74]. However, this approach should be regarded as exploratory and necessitates subsequent robust validation.
For membrane proteins, however, binding-site definition requires an additional level of classification based on the spatial relationship of the pocket to the lipid bilayer. A water-exposed site remains accessible from the extracellular or intracellular aqueous phase and therefore resembles a conventional soluble-protein pocket more closely, although its surrounding topology is still constrained by the transmembrane architecture. By contrast, a protein–lipid interface site is positioned on the membrane-facing surface of the receptor, often in an extrahelical groove or allosteric crevice, where ligand recognition is shaped not only by the protein surface but also by bilayer depth, local polarity, and lipid occupancy [75,76,77]. A buried transmembrane (TM) pocket lies within the helical bundle itself and includes many canonical orthosteric cavities in membrane receptors; in such cases, ligand binding may involve passage through vestibular or otherwise restricted access routes before the final bound conformation is achieved. This classification is not merely descriptive, because solvent exposure, residue composition, desolvation penalties, and ligand-access pathways differ substantially across these site types and can directly influence search-space definition, receptor preparation, and pose interpretation [78,79,80].

4.4. Introducing Receptor Flexibility and Chemistry-Gated Pathways

Once the binding site and, where relevant, its membrane context have been defined, receptor flexibility should be incorporated only to the extent supported by structural or biochemical evidence. A rigid receptor is often sufficient for large-scale screening and may even be preferable when the available structure already represents a suitable holo-like conformation. Limited side-chain flexibility may be appropriate when key residues are known to undergo local adjustments, whereas larger conformational changes may necessitate ensemble docking or induced-fit-like strategies [81,82]. Because these approaches increase computational cost and introduce a greater risk of overfitting, the meaning of receptor flexibility in a given protocol should be defined explicitly [83,84,85].
Interaction chemistry should likewise be treated as an early methodological decision rather than a late-stage refinement. Standard non-covalent docking assumptions are not appropriate for all ligand classes. Covalent ligands require methods that explicitly account for reactive warheads, residue compatibility, and reaction geometry. Reviews of covalent docking have emphasized that it should be considered a distinct methodological branch, and reactive docking approaches such as WIDOCK [86] illustrate how explicit treatment of warhead reactivity can improve both retrospective and prospective covalent screening [87,88,89].

4.5. Structural Quality Assessment Before Docking

Prior to initiating protein preparation, the selected structure should be evaluated for its suitability as a docking target. Relevant considerations include experimental resolution, missing loops, absent side chains, alternate conformations, engineered mutations, crystal-packing artifacts, and local disorder within the binding region. In docking applications, such features are particularly consequential because inaccuracies in the pocket region are often more detrimental than imperfections elsewhere in the structure. Structural quality assessment should therefore be treated as an explicit component of protocol design rather than as an informal preliminary check [90].
For predicted structures, local realism within the binding site is generally more important than global fold accuracy. Recent studies assessing AlphaFold-derived models as docking targets have shown that naive use of predicted structures can reduce docking and virtual-screening performance relative to experimentally determined structures, even when the overall backbone is highly accurate. These studies further suggest that post-processing, removal of low-confidence segments, or flexible treatment of local regions may improve performance, but do not eliminate the need for target-specific scrutiny. Accordingly, confidence assessment should focus primarily on the binding pocket rather than on whole-protein quality scores alone [91,92,93].

4.6. Ligand Preparation

The preparation of ligands determines the specific chemical forms of compounds evaluated in a screening workflow. It is advisable to keep the canonical chemical representations of compounds, like SMILES or SDF, distinct from docking-specific formats such as PDBQT. This separation facilitates the preservation of critical information, including stereochemistry, protonation history, and atom-typing assignments [90,94].
Open Babel remains a fundamental open-source toolkit for file conversion and routine cheminformatics tasks, frequently representing the most efficient choice for compound standardization in screening pipelines [95]. Gypsum-DL is a freely available tool designed for structure-based virtual screening, enabling the generation of screening-ready three-dimensional ligand libraries with configurable enumeration options [96].
Docking workflows utilizing the Vina family typically require the preparation of both ligand and receptor files in PDBQT format. Meeko provides a continuously updated open-source interface for the preparation of AutoDock-compatible inputs and the export of outputs in formats conducive to analysis, such as SDF, thereby minimizing file-format obstacles between docking and subsequent quality control or analysis [97]. The manuscript should present ligand preparation as a clear methodological policy decision. This includes detailing whether protomers, tautomers, and stereoisomers were enumerated, the number of conformers generated, and any filtering criteria applied before docking. The preparation choices for cross-study comparability are often more vital than the selection of closely related docking engines.
Table 2. Preparation and analysis tools for docking and structure-based drug design (SBDD).
Table 2. Preparation and analysis tools for docking and structure-based drug design (SBDD).
SNToolsStagePrimary FunctionTypical ApplicationReference/Official Link
1AutoDockTools/MGLToolsPreparation + visualizationPDBQT preparation scripts, charge/atom typing, box setup, result viewingAutoDock/Vina input preparation[85] https://ccsb.scripps.edu/mgltools/
2AutoSiteBinding-site predictionClusters high-affinity points to define pockets and pseudo-ligandsPocket identification/box definition[98] https://ccsb.scripps.edu/autosite/
3BINANAInteraction analysisGeometry-based receptor–ligand interaction characterizationPost-docking contact classification[99] https://github.com/durrantlab/binana
4DeepPocketDeep-learning pocket detection3D CNN-based site detection and segmentationPocket prediction before blind/local docking[100] https://github.com/devalab/DeepPocket
5Dimorphite-DLProtonation-state enumerationSmall-molecule ionization-state predictionpH-aware ligand preparation[101] https://github.com/durrantlab/dimorphite_dl
6DockRMSDPose comparison/atom mappingGraph-isomorphism-based symmetry-corrected RMSDBenchmarking and pose-evaluation workflows[102] https://aideepmed.com/DockRMSD/
7FpocketPocket detectionVoronoi tessellation/alpha-sphere cavity detectionPocket finding and descriptor extraction[103] https://github.com/Discngine/fpocket
8Gypsum-DLLigand preparationEnumerates ionization/tautomer/chirality/ring forms and builds 3D structuresPreparing docking-ready ligand libraries[96] https://github.com/durrantlab/gypsum_dl
9MeekoLigand/receptor preparation for AutoDockParameterization and PDBQT generationLigands, receptors, flexible side chains, nucleic acids[97] https://meeko.readthedocs.io/
10MolProbity/ReduceStructure validation and hydrogen optimizationAll-atom contact analysis and H placementProtein/nucleic-acid validation before docking[104] https://github.com/rlabduke/MolProbity
11MolscrubLigand state enumeration3D conformer generation, tautomer/protomer enumeration, pH correctionPreparing realistic ligand inputs for dockinghttps://github.com/forlilab/molscrub
12ODDTCheminformatics/docking analysis toolkitUnified Python toolkit for modeling, descriptors, interaction fingerprints, scoringPost-processing, ML descriptors, docking analytics[105] https://github.com/oddt/oddt
13Open BabelLigand/receptor conversion and cleanupFormat conversion, protonation, 3D generation, atom typingInterconversion across docking file formats[95] https://openbabel.github.io/
14Open-Source PyMOLVisualization/analysisMolecular visualizationStructure inspection, binding-mode analysis, figure preparationhttps://github.com/schrodinger/pymol-open-source
15P2RankBinding-site predictionMachine-learning-based protein–ligand binding site predictionPocket prediction before docking[106,107] https://github.com/rdk/p2rank
16PacDOCKWorkflow/post-docking analysisConformation comparison, visualization, and clustering of docking resultsPost-docking analysis and clustering[108] https://pegasus.lbic.unibo.it/pacdock/
17PDB2PQRReceptor electrostatics preparationAssigns charges/radii and creates PQR filesProtonation/electrostatics-aware receptor prep[109] https://pdb2pqr.readthedocs.io/
18PDBFixerReceptor cleanupFixes missing atoms/residues, adds hydrogens/solvent-related correctionsPreparing imperfect PDB structures[110] https://github.com/openmm/pdbfixer
19pdb-toolsPDB file manipulationLightweight CLI editing of PDB structuresChain selection, cleanup, renumbering, extraction[111] https://github.com/haddocking/pdb-tools
20PLIPInteraction analysisRule-based detection and visualization of noncovalent protein–ligand contactsPost-docking interaction profiling[112] https://github.com/pharmai/plip
21PoseBustersPose plausibility checksRule-based quality checks for generated/docked posesPost-generation/post-docking QC[113] https://github.com/maabuu/posebusters
22PoseCheckComplex quality analysisQuality checks for generated protein–ligand complexesPost-prediction QC and comparison[114] https://github.com/cch1999/posecheck
23PPM server (OPM)Structure preparationMembrane positioning/orientationPreparing membrane protein targets before docking or other structure-based studies[115] https://opm.phar.umich.edu/ppm_server
24ProLIFInteraction fingerprintsProtein–ligand interaction fingerprints from docking/MD/structuresPose comparison and interaction-frequency analysis[116] https://github.com/chemosim-lab/ProLIF
25PyViewDockVisualizationPyMOL docking-viewer pluginInspecting and browsing docking poseshttps://github.com/unizar-flav/PyViewDock
26RDKitLigand preparation/cheminformaticsMolecule standardization, descriptors, conformers, substructure logicSMILES/SDF cleanup, enumeration, fingerprints, 3D conformershttps://www.rdkit.org/
27RingtailVirtual-screening result managementSQLite-based storage, filtering, visualization for AutoDock/Vina outputsManaging large docking campaigns[117] https://github.com/forlilab/Ringtail
28sPyRMSDPose comparison/RMSDSymmetry-corrected RMSD in PythonRedocking evaluation and pose clustering[118] https://github.com/RMeli/spyrmsd

4.7. Docking Simulations

Docking is most commonly introduced in the context of small-molecule binding to a defined receptor pocket, where the principal objective is to predict plausible binding poses and rank protein–ligand interactions within a relatively localized search space. In this conventional setting, docking performance depends strongly on binding-site definition, receptor and ligand preparation, sampling strategy, and scoring-function behavior [8,23]. As the size, flexibility, and physicochemical complexity of the interacting partners increase, docking problems become progressively less similar to the classical small-molecule case. For protein–protein, protein–peptide, and protein–nucleic acid docking, the central methodological question is therefore whether a suitable template or experimentally supported interface information is available. When restraints, templates, or biochemical priors exist, data-driven docking can substantially reduce the search space and improve interpretability. HADDOCK is a representative integrative framework in this context, as it explicitly incorporates experimental or predicted interaction information into model generation and refinement [119,120].
In the absence of such prior information, ab initio strategies become necessary, and clustering assumes particular importance because scoring functions alone are often insufficient to identify native-like models within a very large conformational landscape [119,120]. ClusPro exemplifies this principle in protein–protein docking, where cluster populations are central to model selection [121]. For peptide docking, Rosetta FlexPepDock [122] remains an important refinement framework because peptide flexibility and folding upon binding are often the dominant sources of complexity. For protein–DNA and protein–RNA systems, specialized tools such as NPDock [123] reflect the distinct electrostatic and shape-complementarity features of nucleic-acid interfaces and provide integrated workflows for docking, scoring, clustering, and refinement [124,125].
A related but distinct challenge arises when docking problems involve membrane-embedded targets, because in such systems, the bilayer is not merely a structural background but part of the recognition environment itself. When the relevant binding region is located at the protein–lipid interface or within a buried transmembrane environment, the membrane directly influences ligand orientation, access pathways, and local polarity. This point is methodologically important because many conventional docking programs were developed primarily for water-exposed cavities and may not adequately capture membrane depth preferences, lipid-facing polarity, or the bilayer-coupled orientation of lipophilic ligands. For membrane-associated chemotypes, extrahelical allosteric modulators, sterol-like ligands, or other bilayer-partitioning molecules, membrane-aware docking, or at minimum, membrane-informed receptor preparation and post-docking filtering, is therefore preferable to a purely aqueous interpretation of the binding site [77,78,79,80,126,127]. The currently available open-source/free for academic use software ecosystem is summarized in Table 3, and major free and web-accessible docking resources are listed in Table 4.

4.8. Docking Parameters, Sampling Settings, and Reproducibility

A reproducible docking study should report more than the name of the docking engine. At a minimum, the workflow should specify the software version, search exhaustiveness or equivalent sampling depth, number of poses retained, random-seed policy, treatment of receptor flexibility, search-space definition, scoring mode, and any non-default settings. These parameters are not incidental, as they determine the extent of conformational sampling and can materially affect both pose prediction and screening enrichment [18,195].
This level of reporting has become particularly important because many published docking studies remain difficult to reproduce or compare rigorously. Critical analyses of docking-based virtual screening have shown that apparent agreement across studies may conceal major differences in protocol design, validation practice, and data curation. Consequently, parameter reporting, preservation of input files, and transparent description of filtering and post-processing steps should be regarded as integral components of the core methodology rather than as supplementary details [196,197].

4.9. Post-Docking Validation and Potential Refinement

Post-docking analysis should combine at least three elements: assessment of pose plausibility, comparison among alternative poses or clusters, and validation against appropriate controls. In pose-prediction settings, redocking and cross-docking remain informative controls; in screening contexts, discrimination between active and inactive compounds, or between active compounds and decoys, is more relevant. Equally importantly, physically implausible solutions should be filtered even when they receive favorable docking scores. PoseBusters provides a practical example of this principle by evaluating stereochemical validity, steric clashes, bond geometry, ring planarity, and related criteria that conventional RMSD-based assessments may overlook [113].
When rescoring or refinement is applied, it should be presented as support for hypothesis refinement rather than as definitive affinity prediction. Machine-learning-assisted rescoring tools such as GNINA can improve ranking relative to purely empirical scoring in some settings [198], whereas molecular dynamics-based endpoint methods such as MM/PBSA and MM/GBSA may provide additional energetic interpretation after docking [199,200,201,202,203,204]. However, both classes of methods require calibration and careful interpretation. More recent benchmarking initiatives such as PoseBench further highlight that realistic tasks, including apo-to-holo docking and multi-ligand prediction, can expose limitations that are not evident in simplified redocking benchmarks [205].

4.10. Common Failure Modes and Limits of Interpretation

Docking results should ultimately be interpreted within the known limits of the method. High docking scores do not necessarily correspond to accurate binding affinities, and no single docking program performs best across all targets. Benchmarking studies have repeatedly shown that docking and screening power are generally more reliable than affinity ranking power, which remains a major weakness of most scoring functions. This means that docking is usually better suited for pose generation, prioritization, and hypothesis formation than for quantitative prediction of binding free energy [206,207,208,209]. Several recurring sources of overinterpretation should therefore be avoided. Small score differences between closely related ligands are often not meaningful; a visually attractive pose may still be chemically implausible if protonation, tautomerism, water mediation, or receptor conformation are misassigned; and a protocol validated only by redocking may fail in cross-docking, blind docking, or prospective screening. Docking should therefore be presented as one component of an evidence chain that is strengthened by structural data, mutagenesis, biochemical assays, orthogonal screening metrics, or more detailed simulation rather than as a stand-alone proof of mechanism [94,113,210,211,212,213].

5. AI-Augmented Structure-Based Drug Design

5.1. Conceptual Role of AI in SBDD

Artificial intelligence (AI) is continuously incorporated into SBDD as an augmentation rather than a complete substitute for physics-based modeling. In practical SBDD workflows, AI plays a significant role at three levels: the generation of target or complex structures when experimental models are incomplete or unavailable, the navigation of extensive chemical libraries prior to exhaustive docking, and the post-docking rescoring or affinity estimation. The methodological importance of AI is primarily in reorganizing the screening pipeline into a hierarchical process, rather than merely displacing docking. This involves integrating rapid, learned models with physics-based filtering and chemically informed validation. Recent perspectives on modern SBDD emphasize that the most effective workflows increasingly integrate data-driven and physics-based components, rather than viewing them as competing paradigms [1,32]. Representative AI-augmented open-source SBDD tools are outlined in Table 5. Recent comparative benchmarks now make clear that AI methods do not uniformly surpass classical docking across all settings. PoseBench showed that deep-learning co-folding methods often outperform conventional and deep-learning docking baselines in broadly applicable apo-to-holo prediction settings, yet remain challenged by new binding poses and by balancing structural accuracy with chemically faithful protein–ligand interaction patterns [206]. PoseX extended this picture to self-docking and cross-docking and reported that AI-based methods outperformed physics-based methods in overall docking success rate, while also showing that relaxation remains important for improving structural plausibility and that several co-folding models still suffer from ligand chirality errors [214]. By contrast, the recent Bento benchmark provides a more conditional view in pocket-aware, drug-design-relevant settings: classical and deep-learning docking methods were often comparable on regular drug-like ligands, co-folding methods were more clearly advantageous for structurally complex ligands, physics-based methods retained practical speed advantages, and all tested approaches generalized poorly to unseen pockets [215]. Accordingly, the most important methodological question is not whether AI is globally superior to classical docking, but which model class is most appropriate for a specific structural regime and decision point within the SBDD workflow.

5.2. Structural Availability and AI-Assisted Model Generation

The initial decision point in an AI-augmented SBDD workflow involves determining the availability of a high-quality holo structure (Figure 5). In the presence of such a structure, conventional docking serves as the methodological baseline, with AI being most effectively integrated downstream via rescoring, rank fusion, or prioritization. In the absence of suitable experimental complexes, recent co-folding and all-atom structure-prediction models offer a viable alternative for constructing initial receptor–ligand hypotheses. AlphaFold3 has shown that it is possible to jointly predict complexes that include proteins, nucleic acids, small molecules, ions, and modified residues within a single model framework [216]. Meanwhile, RoseTTAFold all-atom has expanded these concepts to encompass generalized biomolecular modeling and design [217]. Open tools such as Boltz-1 [218] and Chai-1 [28] expand access to co-folding-style workflows. The preprint detailing Boltz-2 indicates that foundation models may increasingly integrate structure prediction with affinity estimation [27]. Because these methods are supported wholly or partly by preprint-stage literature, their reported performance should be interpreted cautiously and regarded as provisional pending broader independent validation and peer-reviewed assessment. Accordingly, they are best viewed here as promising emerging developments rather than fully established standards in AI-augmented SBDD.
These advancements are particularly significant for apo targets, orphan targets, and novel proteins lacking ligand-bound structures. At the same time, AI-generated complexes should still be treated as candidate hypotheses rather than validated binding modes. Recent PoseBench, PoseX and Bento benchmarks support the use of AI structure generation primarily as a hypothesis-enabling layer for difficult apo, cross-docking, or high-flexibility scenarios, not as a universal replacement for experimentally anchored docking protocols [205,214,215].

5.3. AI-Enabled Navigation of Ultra-Large Chemical Space

AI significantly contributes to modern SBDD by facilitating an examination of chemical space before the docking process. The expansion of make-on-demand libraries from millions to billions of compounds has rendered naïve exhaustive docking increasingly challenging to implement in standard academic workflows. Extensive prospective studies indicate that increasing library size can uncover novel chemotypes and enhance hit discovery; however, this necessitates efficient library triage as an operational requirement. Vector-based molecular representations and approximate nearest-neighbor indexing provide an effective means to minimize the search space prior to the implementation of more resource-intensive physics-based methods. Embeddings produced by graph neural network systems like Chemprop, when integrated with efficient graph-based search structures such as hierarchical navigable small world (HNSW) indices, facilitate the retrieval of chemically plausible subsets for docking, eliminating the need for exhaustive brute-force evaluation of the complete library. Retrieval-augmented docking (RAD) is a hierarchical screening framework that utilizes molecular vectorization and approximate nearest-neighbor retrieval to minimize ultra-large compound libraries before implementing physics-based docking on the selected subset. This is regarded as an engineering layer for prioritization rather than a substitute for docking itself [219,220,221,222,223].
Practically, AI can be deployed at the Tier-0 stage to identify a manageable subset from an otherwise intractable library, allowing conventional high-throughput docking to proceed on the reduced set (Figure 6). This technique is especially appealing when the initial collection is chemically varied and synthetically attainable, yet excessively vast for comprehensive screening using local resources. The significance of RAD is not that it removes the need for energetic evaluation but that it concentrates docking effort on compounds that are more likely to occupy relevant regions of chemical space [219,222].

5.4. Physics-Based Filtering of AI-Prioritized Libraries

Following AI-based reduction in the screening library, a high-throughput physics-based layer remains essential. At this stage, rapid rigid or minimally flexible docking serves as the initial physically interpretable filter, eliminating compounds that are geometrically implausible or energetically unfavorable within the binding site. For standard protein targets, engines such as AutoDock Vina and rDock remain useful baseline platforms because they are computationally efficient, readily scriptable, and well established in large-scale screening workflows. In AI-augmented pipelines, their role is therefore not displaced but repositioned as the first energetically grounded filtering step applied after AI-driven library refinement [212].
Selection of the docking engine should remain guided by the underlying chemistry of the target. Metalloenzymes, in particular, often demand metal-aware treatment because standard scoring functions may fail to reproduce coordination geometries and electrostatic interactions with sufficient reliability. AutoDock4Zn is an example of a specialized extension designed for zinc-containing systems, and the broader docking literature continues to identify metalloproteins as a persistent challenge. In difficult cases, local quantum-mechanical or QM/MM validation may offer a more chemically faithful assessment of coordination geometry than classical scoring alone. By contrast, peptide binders present a different limitation: conventional small-molecule docking engines are often poorly suited to systems in which peptide flexibility and folding upon binding dominate the search landscape. Methods such as CABS-dock were developed specifically for this setting and permit flexible protein–peptide docking without the need to prespecify a binding site [160,224,225,226].
Table 5. AI-augmented tools for docking and structure-based drug design (SBDD).
Table 5. AI-augmented tools for docking and structure-based drug design (SBDD).
SNToolsStageAI ParadigmTypical ApplicationReference/Official Link
1Boltz-2Complex structure/affinity predictionDiffusion co-folding modelPose generation; affinity scoring[27] https://github.com/jwohlwend/boltz
2CarsiDockDL-guided dockingPretrained deep learning-guided dockingPose prediction/ranking[227] https://github.com/carbonsilicon-ai/CarsiDock
3Chai-1Complex structure predictionMultimodal foundation modelPose/complex generation[28] https://github.com/chaidiscovery/chai-lab
4Deep Docking (DD protocol)AI-accelerated virtual screeningQSAR/deep models trained on docking subsets to prune huge librariesBillion-scale VS acceleration[228] https://github.com/jamesgleave/DD_protocol
5DeltaDockMolecular dockingUnified deep learning frameworkDocking and robust benchmarking[229] https://github.com/jiaxianyan/DeltaDock
6DiffBindFRFlexible dockingSE(3)-equivariant diffusion frameworkFlexible protein–ligand docking[230] https://github.com/HBioquant/DiffBindFR
7DiffDockPose prediction/blind dockingSE(3)-equivariant diffusion modelPose generation and ranking[231] https://github.com/gcorso/DiffDock
8DynamicBindFully flexible complex predictionEquivariant generative model/diffusion-style learningFlexible protein–ligand complex modeling[232] https://github.com/luwei0917/DynamicBind
9EBMDockProtein–protein dockingDifferentiable energy-based modelPose sampling/ranking[233] https://github.com/wuhuaijin/EBMDock
10EquiBindPose prediction/blind dockingSE(3)-equivariant geometric deep learningFast direct pose prediction[234] https://github.com/HannesStark/EquiBind
11FABind/FABind+Pose prediction/blind dockingGeometric deep learning with improved pocket predictionFast blind docking[235] https://github.com/QizhiPei/FABind
12FlowDockGenerative docking + affinity predictionGeometric flow matchingJoint structure and affinity modeling[236] https://github.com/BioinfoMachineLearning/FlowDock
13GNINADocking + rescoring3D convolutional neural networks on atom gridsDrop-in docking engine/rescoring layer[198,237] https://github.com/gnina/gnina
14KarmaDockDocking acceleration + pose generation + scoringDeep learning model combining pose correction and strength estimationHigh-throughput AI docking[238] https://github.com/schrojunzhang/KarmaDock
15NeuralPLexerComplex structure predictionMultiscale deep generative modelProtein–ligand structure prediction[239] https://github.com/zrqiao/NeuralPLexer
16Open-ComBindData-driven pose selectionPhysics-based docking + learned cross-ligand consistencyPose selection/affinity-related ranking[240] https://github.com/drewnutt/open_combind
17OpenDockDocking framework with ML scoringPyTorch framework with traditional and ML scoring functionsMethod development and docking[60] https://github.com/guyuehuo/opendock
18OpenFold3-previewComplex structure predictionAF3-based co-folding modelPose/complex generation[241] https://github.com/aqlaboratory/openfold-3
19Open-source DD protocol (optimized)AI-accelerated virtual screeningOpen implementation of deep docking workflowLarge-library pruning and analysis[242] https://github.com/MichaelaBrezinova/open_source_deep_docking_protocol
20PILOT (e3moldiffusion)Pocket-conditioned multi-objective generationEquivariant diffusion with guided generationGenerative SBDD/optimization[243] https://github.com/pfizer-opensource/e3moldiffusion
21Pocket2MolPocket-conditioned de novo designEquivariant autoregressive generative modelHit generation inside pockets[244] https://github.com/pengxingang/Pocket2Mol
22PPDOCKBlind dockingPocket-prediction-based protein–ligand dockingEnd-to-end blind docking[245] https://github.com/JieDuTQS/PPDOCK
23RoseTTAFold All-AtomProtein–ligand/complex predictionAll-atom deep structure modelPose/complex generation[217] https://github.com/baker-laboratory/RoseTTAFold-All-Atom
24RTMScoreML rescoring/scoring functionGraph transformer + residue-atom distance likelihood potentialRescoring poses/affinity-related scoring[246] https://github.com/sc8668/RTMScore
25SampleDockGenerative-design + docking loopIterative generative model coupled to dockingLead-generation workflow[247] https://github.com/atfrank/SampleDock
26SurfDockComplex prediction/screeningSurface-informed diffusion modelPose prediction and screening[248] https://github.com/CAODH/SurfDock
27TankBindPose + affinity predictionGeometric deep learning on protein pocket/ligand graphsPose generation plus affinity estimation[249] https://github.com/luwei0917/TankBind
28TargetDiffPocket-conditioned de novo design3D equivariant diffusion modelGenerative SBDD/affinity-aware design[250] https://github.com/guanjq/targetdiff
29Uni-Mol (Docking)3D representation learning for docking/SBDDLarge-scale 3D molecular + pocket pretrainingBinding conformation prediction and broader SBDD tasks[25,251] https://github.com/deepmodeling/Uni-Mol

5.5. AI Rescoring, Affinity Prediction, and Consensus Ranking

Once a reduced set of docked complexes is available, the most natural role for AI is in rescoring and rank refinement. GNINA is the canonical open implementation of this strategy, incorporating convolutional neural-network (CNN) scoring into the docking workflow and showing improved virtual-screening performance relative to empirical scoring alone on several benchmark datasets. In this setting, AI does not supplant docking-based pose generation, but instead reevaluates candidate poses through learned spatial representations of protein–ligand contacts. This distinction is consequential, because CNN-based rescoring is generally most effective when applied to poses that have already satisfied a reasonable physics-based filter [237,252,253].
A second, more ambitious use of AI is affinity prediction. Recent foundation models aim not only to recover bound structures, but also to estimate quantitative binding strength directly from the modeled complex. Boltz-2 serves as a notable recent example; however, given its status as a preprint, its performance must be interpreted with caution until further external validation is conducted. These methods are therefore best framed as emerging tools for affinity-aware prioritization rather than as mature replacements for established binding assays or rigorously calibrated free-energy workflows. Moreover, consensus strategies can enhance ranking stability when multiple scoring outputs are present. Simple rank-fusion methods, such as reciprocal rank fusion, are particularly advantageous as they enable the integration of heterogeneous signals without necessitating direct normalization across fundamentally distinct scoring frameworks [27,254,255].

5.6. Validation of Physical Plausibility and Binding Interactions

AI-augmented SBDD should include a dedicated validity gate between model generation and final candidate nomination. This has become particularly important because high-ranking AI-generated poses can still violate fundamental stereochemical or steric constraints. PoseBusters offers a practical framework for this stage by assessing chemically and physically meaningful features of predicted complexes, and it was developed specifically in response to the tendency of several AI docking methods to produce poses that are visually persuasive yet physically invalid. More broadly, these findings highlight an important methodological point: ranking quality and physical plausibility are distinct criteria and must be evaluated independently [113,205].
Following physical filtering, interaction-level validation provides an additional layer of assessment. Tools such as PLIP can systematically annotate hydrogen bonds, hydrophobic contacts, salt bridges, metal interactions, and aromatic contacts in docked or predicted complexes, helping to determine whether retained poses are consistent with known pharmacophoric requirements or mechanistic expectations. This step is especially useful when AI rescoring and classical docking yield discordant results, because interaction profiling can help distinguish chemically sensible poses from those that are merely algorithmically preferred. At this stage, expert visual inspection in PyMOL or ChimeraX remains essential, particularly when the aim is to nominate compounds for synthesis or procurement rather than to maximize performance on a benchmarking task [112,113].

5.7. AI Strategies Across Distinct Target Classes

The utility of AI augmentation varies substantially across target classes. For standard proteins with high-quality holo structures, AI is often most effective downstream, particularly in rescoring, consensus ranking, and interaction-based triage. For apo or structurally uncharacterized targets, however, AI-based structure generation may serve as the enabling step for SBDD, provided that the resulting complexes are rigorously validated [256]. In metalloenzymes, AI may assist prioritization, but chemically specialized scoring and, when necessary, QM-informed refinement remain indispensable because metal coordination is still not captured reliably by generic learned models [225,257,258]. Likewise, for peptide binders, AI-generated starting complexes can be informative, but peptide-specific docking and refinement remain necessary because peptide conformational plasticity is poorly approximated by small-molecule frameworks [160,259].
A further limitation concerns binding-site type. Current evidence indicates that co-folding approaches are generally more dependable for canonical orthosteric binding than for allosteric recognition, where both site identification and pose recovery are often more challenging. Accordingly, in AI-augmented SBDD, co-folding should be treated as a hypothesis-generating approach when the site is uncertain, rather than as definitive proof of binding mode [29,260]. In these settings, pocket analysis, orthogonal docking, mutational evidence, and experimental validation remain particularly important.

5.8. Reporting Standards, Reproducibility, and Interpretation Limits

Because AI-augmented SBDD comprises multiple interdependent stages, reproducibility depends on transparent reporting across the full workflow. A rigorous study should clearly document how the target structure was obtained or generated; whether templates, ligands, multiple-sequence alignments (MSAs), or restraints were supplied to the predictive model; how the chemical library was represented and reduced; which docking engine and associated parameters were employed; whether AI-based rescoring or affinity prediction was applied; how consensus ranking was conducted; and which physical or interaction-level filters were imposed before final candidate nomination. Without this level of reporting, cross-study comparisons remain difficult to interpret, because observed gains may derive from differences in data curation, target preparation, or triage strategy rather than from the AI methodology itself [22,205,261,262].
More broadly, AI-augmented SBDD should be regarded as a framework for prioritization rather than as proof of binding mode or biological efficacy. The current generation of models has undoubtedly expanded the scope of feasible structure prediction and docking tasks, yet benchmark studies continue to expose persistent weaknesses in generalization to novel sequences, multiligand assemblies, chemically challenging targets, and the production of physically valid poses. AI is therefore most powerful when used as a layered accelerator that reduces search space, improves ranking, and enhances hypothesis generation, while remaining firmly coupled to chemistry-aware docking, plausibility checks, and experimental validation [43,113,205,263].

6. Challenges and Opportunities

Open availability does not automatically eliminate infrastructure and interoperability barriers. Although open-source tools substantially reduce licensing costs, they do not fully remove practical asymmetries in access. This is increasingly evident in AI-enhanced SBDD workflows, where computational demand can shift the bottleneck from software cost to hardware availability. For example, AutoDock-GPU explicitly targets CUDA- and OpenCL-enabled accelerators and reports substantial speedups relative to serial AutoDock4, while GNINA integrates convolutional neural-network scoring and documents GPU-dependent operating modes, with some CNN workflows becoming markedly more expensive when used beyond simple rescoring. Similarly, recent evaluations of co-folding methods such as RoseTTAFold All-Atom [33,217] and Boltz-1 [218] have been conducted on A100 80 GB hardware, underscoring that some openly available structure-prediction workflows remain demanding to deploy routinely at scale. From this perspective, the distinction between open and easily deployable remains significant. A method may be openly licensed and scientifically valuable while nevertheless remaining difficult to reproduce in resource-constrained environments owing to requirements for specialized accelerators, substantial memory, or complex systems integration.
Interoperability remains a second, closely related challenge. Contemporary open-source SBDD workflows rarely rely on a single program; instead, they typically combine cheminformatics libraries, preparation tools, docking engines, rescoring models, and post-docking analysis utilities. This has improved markedly with the availability of interoperability-focused tools such as Open Babel for file-format conversion and cheminformatics processing, Meeko for molecular parameterization and docking-oriented software interoperability, and PLIP [112] for structured interaction profiling suitable for downstream processing. However, the very need for such bridging tools also highlights that workflow exchange is still not frictionless across groups. More broadly, reproducibility studies in computational drug discovery continue to emphasize that workflows, pipelines, and research documentation are essential for making multistage analyses reusable, while recent open-science perspectives in cheminformatics stress the importance of harmonized data formats and robust exchange platforms. Taken together, these developments suggest that the key challenge is no longer the absence of open tools, but the absence of uniformly adopted, low-friction standards for connecting mature tools into transparent, portable, and well-documented scientific workflows. The opportunity, therefore, lies not only in developing new methods but also in standardizing interfaces, workflow metadata, and reporting practices so that open pipelines become easier to exchange, audit, and reproduce across laboratories.

7. Future Perspectives

One of the most important future priorities for open-source SBDD will be to reduce the gap between formal software openness and real-world deployability. While source-code availability remains a foundational requirement, it does not in itself guarantee that methods can be installed, executed, and reproduced reliably across heterogeneous research settings. Addressing this gap will require sustained emphasis on hardware-efficient inference, containerized and reproducible software distribution, richer workflow metadata, and more robust interoperability standards linking ligand and receptor preparation, docking, rescoring, and post-docking analysis.
More fundamentally, the next phase of progress is likely to depend on a transition from tool-centered innovation to ecosystem-level sustainability. For open-source docking to achieve long-term maturity, maintenance must be recognized as a core component of research infrastructure rather than as an informal activity that follows initial publication. This requires more durable governance models, clearer ownership structures, and funding mechanisms capable of extending beyond the lifespan of individual grants, trainees, or laboratories. In this context, a central lesson is that future progress will depend not only on the introduction of new scoring functions, search algorithms, or artificial intelligence modules, but also on the sustained maintenance, validation, documentation, and stewardship of the tools that already underpin the field.
A second important direction concerns formal succession planning and modular renewal. The docking ecosystem already offers several constructive examples in which replacement has occurred through redesign rather than abrupt obsolescence. Meeko [97] has increasingly displaced MGLTools-based preparation workflows, pydock3 has emerged as a successor to DOCK Blaster and blastermaster [264], and AutoDock Vina has continued to evolve through Python bindings, batch-processing capabilities, and active release cycles [132,157]. Together, these developments suggest a healthier model in which software is restructured into interoperable layers rather than preserved indefinitely as closed or aging monoliths. An important future opportunity is to institutionalize this practice more explicitly by encouraging software projects to define transparent deprecation policies, identify recommended successors, document compatibility boundaries, and provide migration guides so that users can move across software generations without rebuilding workflows from scratch.
Usability-by-design should also be regarded as a strategic priority. Open-source docking will expand its scientific reach only if it becomes easier for non-specialist users to install, operate, interpret, and audit. Recent developments already point in this direction. MolModa illustrates one pathway through browser-based accessibility [184], whereas AutoDock Vina [18,132] and GNINA [198] illustrate another through improved documentation, official binaries, and container-oriented deployment. Future progress should therefore extend beyond methodological sophistication alone and include clearer default workflows, more robust installation pathways, better tutorials and worked examples, and a stronger focus on the practical experience of new users. Within open-source SBDD, accessibility is no longer a secondary concern; it is a prerequisite for wider adoption, community growth, and durable maintenance.
Finally, the long-term health of open-source docking will depend on managed diversity rather than unchecked proliferation. Software forks are likely to remain an important source of experimentation and innovation, but their enduring value depends on transparent documentation, visible maintenance status, sound governance, and interoperability with the broader ecosystem. The most productive software lineages are not those that merely generate multiple variants, but those that make the relationships among parent tools, forks, and successors intelligible to users. The histories of rDock [265] and RxDock [151,266], as well as Vina [156,158,267], smina [153], and GNINA [253], illustrate that the next stage of maturity will require better curation of project lineages, richer metadata, and clearer signals regarding which tools are legacy systems, which are transitional, and which remain actively supported. Open-source docking will be strongest when innovation through diversity remains possible, while maintenance status, migration pathways, and interoperability are made explicit rather than left for users to infer.

8. Conclusions

In conclusion, open-source molecular docking and AI-augmented SBDD are rapidly evolving from collections of individual tools into steadily integrated and methodologically sophisticated discovery pipelines. Despite significant limitations, especially regarding affinity ranking, receptor-state uncertainty, chemical-state assignment, and benchmark realism, the field has evidently advanced beyond mere low-cost alternatives to commercial software. The current strength is found in the increasing capacity to integrate transparent preparation protocols, scalable docking engines, machine-learning-assisted rescoring, emerging co-folding strategies, and reproducible validation schemes within fully auditable workflows. The future influence of this ecosystem will rely not on the ability of any single method to address all facets of molecular recognition, but on the effectiveness of integrating, benchmarking, and reporting complementary approaches. As methodological standards advance, open-source and AI-enabled SBDD will increasingly contribute to enhancing the rigor, accessibility, and reproducibility of computational drug discovery.

Author Contributions

Conceptualization, F.A. and S.A.A.; methodology, F.A. and S.A.A.; validation, F.A.; formal analysis, F.A.; investigation, F.A.; resources, F.A. and S.A.A.; data curation, F.A.; writing—original draft preparation, F.A.; writing—review and editing, F.A. and S.A.A.; visualization, F.A.; supervision, S.A.A.; funding acquisition, F.A. All authors have read and agreed to the published version of the manuscript.

Funding

Open access publication of this article was made possible through funding of the article processing charge by the Deanship of Graduate Studies and Scientific Research at Qassim University (QU-APC-2026).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Acknowledgments

The researchers would like to thank the Deanship of Graduate Studies and Scientific Research at Qassim University for financial support (QU-APC-2026).

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Lam, J.H.; Katritch, V. Navigating Structure-Based Drug Discovery with Emerging Innovations in Physics- and Knowledge-Based Approaches. npj Drug Discov. 2025, 2, 29. [Google Scholar] [CrossRef]
  2. Wu, K.; Karapetyan, E.; Schloss, J.; Vadgama, J.; Wu, Y. Advancements in Small Molecule Drug Design: A Structural Perspective. Drug Discov. Today 2023, 28, 103730. [Google Scholar] [CrossRef] [PubMed]
  3. Berman, H.M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T.N.; Weissig, H.; Shindyalov, I.N.; Bourne, P.E. The Protein Data Bank. Nucleic Acids Res. 2000, 28, 235–242. [Google Scholar] [CrossRef]
  4. Burley, S.K.; Berman, H.M. Open-Access Data: A Cornerstone for Artificial Intelligence Approaches to Protein Structure Prediction. Structure 2021, 29, 515–520. [Google Scholar] [CrossRef]
  5. Bugnon, M.; Röhrig, U.F.; Goullieux, M.; Perez, M.A.S.; Daina, A.; Michielin, O.; Zoete, V. SwissDock 2024: Major Enhancements for Small-Molecule Docking with Attracting Cavities and AutoDock Vina. Nucleic Acids Res. 2024, 52, W324–W332. [Google Scholar] [CrossRef]
  6. Perez-Riverol, Y.; Bittremieux, W.; Noble, W.S.; Martens, L.; Bilbao, A.; Lazear, M.R.; Grüning, B.; Katz, D.S.; MacCoss, M.J.; Dai, C.; et al. Open-Source and FAIR Research Software for Proteomics. J. Proteome Res. 2025, 24, 2222–2234. [Google Scholar] [CrossRef]
  7. McDonald, C.J.; Schadow, G.; Barnes, M.; Dexter, P.; Overhage, J.M.; Mamlin, B.; McCoy, J.M. Open Source Software in Medical Informatics—Why, How and What. Int. J. Med. Inform. 2003, 69, 175–184. [Google Scholar] [CrossRef] [PubMed]
  8. Ma, Z.; Ajibade, A.; Zou, X. Docking Strategies for Predicting Protein-Ligand Interactions and Their Application to Structure-Based Drug Design. Commun. Inf. Syst. 2024, 24, 199–230. [Google Scholar] [CrossRef]
  9. Agu, P.C.; Afiukwa, C.A.; Orji, O.U.; Ezeh, E.M.; Ofoke, I.H.; Ogbu, C.O.; Ugwuja, E.I.; Aja, P.M. Molecular Docking as a Tool for the Discovery of Molecular Targets of Nutraceuticals in Diseases Management. Sci. Rep. 2023, 13, 13398. [Google Scholar] [CrossRef] [PubMed]
  10. Fan, J.; Fu, A.; Zhang, L. Progress in Molecular Docking. Quant. Biol. 2019, 7, 83–89. [Google Scholar] [CrossRef]
  11. Nivatya, H.K.; Singh, A.; Kumar, N.; Sonam; Sharma, L.; Singh, V.; Mishra, R.; Gaur, N.; Mishra, A.K. Assessing Molecular Docking Tools: Understanding Drug Discovery and Design. Futur. J. Pharm. Sci. 2025, 11, 111. [Google Scholar] [CrossRef]
  12. Azam, F.; Alabdullah, N.H.; Ehmedat, H.M.; Abulifa, A.R.; Taban, I.; Upadhyayula, S. NSAIDs as Potential Treatment Option for Preventing Amyloid β Toxicity in Alzheimer’s Disease: An Investigation by Docking, Molecular Dynamics, and DFT Studies. J. Biomol. Struct. Dyn. 2018, 36, 2099–2117. [Google Scholar] [CrossRef]
  13. Alghamdi, M.A.; Azam, F.; Jamir Anwar, M.; Mahmood, D.; Ali, M.A.M.; Khan, M. Isoniazid Derivatives as Potential Lipoxygenase-15 Inhibitors: In-Vitro and In-Silico Studies. ChemistrySelect 2024, 9, e202401772. [Google Scholar] [CrossRef]
  14. Muhammed, M.T.; Aki-Yalcin, E. Molecular Docking: Principles, Advances, and Its Applications in Drug Discovery. Lett. Drug Des. Discov. 2024, 21, 480–495. [Google Scholar] [CrossRef]
  15. Corrêa Veríssimo, G.; Salgado Ferreira, R.; Gonçalves Maltarollo, V. Ultra-Large Virtual Screening: Definition, Recent Advances, and Challenges in Drug Design. Mol. Inform. 2025, 44, e202400305. [Google Scholar] [CrossRef] [PubMed]
  16. Eisenhuth, P.; Liessmann, F.; Moretti, R.; Meiler, J. Ultra-Large Library Screening with an Evolutionary Algorithm in Rosetta (REvoLd). Commun. Chem. 2025, 8, 335. [Google Scholar] [CrossRef]
  17. Tripathi, A.; Bankaitis, V.A. Molecular Docking: From Lock and Key to Combination Lock. J. Mol. Med. Clin. Appl. 2017, 2. [Google Scholar] [CrossRef]
  18. Trott, O.; Olson, A.J. AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading. J. Comput. Chem. 2010, 31, 455–461. [Google Scholar] [CrossRef]
  19. Alghamdi, M.A.; Azam, F.; Alam, P. Deciphering Campylobacter Jejuni DsbA1 Protein Dynamics in the Presence of Anti-Virulent Compounds: A Multi-Pronged Computer-Aided Approach. J. Biomol. Struct. Dyn. 2024, 43, 4388–4404. [Google Scholar] [CrossRef]
  20. Liu, Y.; Yang, X.; Gan, J.; Chen, S.; Xiao, Z.-X.; Cao, Y. CB-Dock2: Improved Protein–Ligand Blind Docking by Integrating Cavity Detection, Docking and Homologous Template Fitting. Nucleic Acids Res. 2022, 50, W159–W164. [Google Scholar] [CrossRef]
  21. Grosdidier, A.; Zoete, V.; Michielin, O. SwissDock, a Protein-Small Molecule Docking Web Service Based on EADock DSS. Nucleic Acids Res. 2011, 39, W270–W277. [Google Scholar] [CrossRef] [PubMed]
  22. Schaduangrat, N.; Lampa, S.; Simeon, S.; Gleeson, M.P.; Spjuth, O.; Nantasenamat, C. Towards Reproducible Computational Drug Discovery. J. Cheminform. 2020, 12, 9. [Google Scholar] [CrossRef]
  23. Sim, J.; Kim, D.; Kim, B.; Choi, J.; Lee, J. Recent Advances in AI-Driven Protein-Ligand Interaction Predictions. Curr. Opin. Struct. Biol. 2025, 92, 103020. [Google Scholar] [CrossRef]
  24. Wu, M.-H.; Xie, Z.; Zhi, D. A Folding-Docking-Affinity Framework for Protein-Ligand Binding Affinity Prediction. Commun. Chem. 2025, 8, 108. [Google Scholar] [CrossRef] [PubMed]
  25. Zhou, G.; Gao, Z.; Ding, Q.; Zheng, H.; Xu, H.; Wei, Z.; Zhang, L.; Ke, G. Uni-Mol: A Universal 3D Molecular Representation Learning Framework. ChemRxiv 2023. [Google Scholar] [CrossRef]
  26. Bryant, P.; Kelkar, A.; Guljas, A.; Clementi, C.; Noé, F. Structure Prediction of Protein-Ligand Complexes from Sequence Information with Umol. Nat. Commun. 2024, 15, 4536. [Google Scholar] [CrossRef] [PubMed]
  27. Passaro, S.; Corso, G.; Wohlwend, J.; Reveiz, M.; Thaler, S.; Somnath, V.R.; Getz, N.; Portnoi, T.; Roy, J.; Stark, H.; et al. Boltz-2: Towards Accurate and Efficient Binding Affinity Prediction. bioRxiv 2025. [Google Scholar] [CrossRef]
  28. Discovery, C.; Boitreaud, J.; Dent, J.; McPartlon, M.; Meier, J.; Reis, V.; Rogozhnikov, A.; Wu, K. Chai-1: Decoding the Molecular Interactions of Life. bioRxiv 2024. [Google Scholar] [CrossRef]
  29. Nittinger, E.; Yoluk, Ö.; Tibo, A.; Olanders, G.; Tyrchan, C. Co-Folding, the Future of Docking—Prediction of Allosteric and Orthosteric Ligands. Artif. Intell. Life Sci. 2025, 8, 100136. [Google Scholar] [CrossRef]
  30. Cournia, Z.; Chipot, C.; Roux, B.; York, D.M.; Sherman, W. Free Energy Methods in Drug Discovery—Introduction. In Free Energy Methods in Drug Discovery: Current State and Future Directions; ACS Symposium Series; American Chemical Society: Washington, DC, USA, 2021; Volume 1397, p. 1. [Google Scholar]
  31. Thaler, S.; Wu, Z.; Glass, W.G.; Bradshaw, R.T.; Tossou, P.; Wood, G.P.F. Boltz-ABFE: Free Energy Perturbation without Crystal Structures. arXiv 2025, arXiv:2508.19385. [Google Scholar] [CrossRef]
  32. Wei, H.; McCammon, J.A. Structure and Dynamics in Drug Discovery. npj Drug Discov. 2024, 1, 1. [Google Scholar] [CrossRef]
  33. Masters, M.R.; Mahmoud, A.H.; Lill, M.A. Investigating Whether Deep Learning Models for Co-Folding Learn the Physics of Protein-Ligand Interactions. Nat. Commun. 2025, 16, 8854. [Google Scholar] [CrossRef] [PubMed]
  34. Sindt, F.; Rognan, D. Structure-Based Virtual Screening of Ultra-Large Chemical Spaces: Advances and Pitfalls. Eur. J. Med. Chem. 2026, 305, 118576. [Google Scholar] [CrossRef]
  35. Enamine—REAL Space. Available online: https://enamine.net/compound-collections/real-compounds/real-space-navigator? (accessed on 2 February 2026).
  36. Raasveldt, M.; Mühleisen, H. DuckDB: An Embeddable Analytical Database. In Proceedings of the 2019 International Conference on Management of Data; Association for Computing Machinery: New York, NY, USA, 2019; pp. 1981–1984. [Google Scholar]
  37. Chemical Computing Group ULC. Molecular Operating Environment (MOE), version 2026; Chemical Computing Group ULC: Montreal, QC, Canada, 2026. [Google Scholar]
  38. Schrödinger LLC. Schrödinger Release Notes, version 2026-1: Glide 2025; Schrödinger LLC: New York, NY, USA, 2026. [Google Scholar]
  39. Jones, G.; Willett, P.; Glen, R.C.; Leach, A.R.; Taylor, R. Development and Validation of a Genetic Algorithm for Flexible Docking. J. Mol. Biol. 1997, 267, 727–748. [Google Scholar] [CrossRef]
  40. Steinbeck, C. The Evolution of Open Science in Cheminformatics: A Journey from Closed Systems to Collaborative Innovation. J. Cheminform. 2025, 17, 44. [Google Scholar] [CrossRef]
  41. Murail, S.; de Vries, S.J.; Rey, J.; Moroy, G.; Tufféry, P. SeamDock: An Interactive and Collaborative Online Docking Resource to Assist Small Compound Molecular Docking. Front. Mol. Biosci. 2021, 8, 716466. [Google Scholar] [CrossRef]
  42. Guedes, I.A.; Costa, L.S.C.; dos Santos, K.B.; Karl, A.L.M.; Rocha, G.K.; Teixeira, I.M.; Galheigo, M.M.; Medeiros, V.; Krempser, E.; Custódio, F.L.; et al. Drug Design and Repurposing with DockThor-VS Web Server Focusing on SARS-CoV-2 Therapeutic Targets and Their Non-Synonym Variants. Sci. Rep. 2021, 11, 5543. [Google Scholar] [CrossRef]
  43. Lyu, J.; Kapolka, N.; Gumpper, R.; Alon, A.; Wang, L.; Jain, M.K.; Barros-Álvarez, X.; Sakamoto, K.; Kim, Y.; DiBerto, J.; et al. AlphaFold2 Structures Guide Prospective Ligand Discovery. Science 2024, 384, eadn6354. [Google Scholar] [CrossRef]
  44. Zhou, G.; Rusnac, D.-V.; Park, H.; Canzani, D.; Nguyen, H.M.; Stewart, L.; Bush, M.F.; Nguyen, P.T.; Wulff, H.; Yarov-Yarovoy, V.; et al. An Artificial Intelligence Accelerated Virtual Screening Platform for Drug Discovery. Nat. Commun. 2024, 15, 7761. [Google Scholar] [CrossRef]
  45. Stein, R.M.; Kang, H.J.; McCorvy, J.D.; Glatfelter, G.C.; Jones, A.J.; Che, T.; Slocum, S.; Huang, X.-P.; Savych, O.; Moroz, Y.S.; et al. Virtual Discovery of Melatonin Receptor Ligands to Modulate Circadian Rhythms. Nature 2020, 579, 609–614. [Google Scholar] [CrossRef] [PubMed]
  46. Kaplan, A.L.; Confair, D.N.; Kim, K.; Barros-Álvarez, X.; Rodriguiz, R.M.; Yang, Y.; Kweon, O.S.; Che, T.; McCorvy, J.D.; Kamber, D.N.; et al. Bespoke Library Docking for 5-HT(2A) Receptor Agonists with Antidepressant Activity. Nature 2022, 610, 582–591. [Google Scholar] [CrossRef]
  47. Gahbauer, S.; DeLeon, C.; Braz, J.M.; Craik, V.; Kang, H.J.; Wan, X.; Huang, X.-P.; Billesbølle, C.B.; Liu, Y.; Che, T.; et al. Docking for EP4R Antagonists Active against Inflammatory Pain. Nat. Commun. 2023, 14, 8067. [Google Scholar] [CrossRef]
  48. Cabeza de Vaca, I.; Trapkov, B.; Shen, L.; Vo, D.D.; Zhang, X.; Yang, Y.; Pezeshki, M.; Zhang, X.; Bällgren, F.; Saleh, A.; et al. Ultra-Large Virtual Screening Unveils Potent Agonists of the Neuromodulatory Orphan Receptor GPR139. Nat. Commun. 2026, 17, 129. [Google Scholar] [CrossRef] [PubMed]
  49. Tummino, T.A.; Iliopoulos-Tsoutsouvas, C.; Braz, J.M.; O’Brien, E.S.; Stein, R.M.; Craik, V.; Tran, N.K.; Ganapathy, S.; Liu, F.; Shiimura, Y.; et al. Virtual Library Docking for Cannabinoid-1 Receptor Agonists with Reduced Side Effects. Nat. Commun. 2025, 16, 2237. [Google Scholar] [CrossRef] [PubMed]
  50. Díaz-Holguín, A.; Saarinen, M.; Vo, D.D.; Sturchio, A.; Branzell, N.; Cabeza de Vaca, I.; Hu, H.; Mitjavila-Domènech, N.; Lindqvist, A.; Baranczewski, P.; et al. AlphaFold Accelerated Discovery of Psychotropic Agonists Targeting the Trace Amine-Associated Receptor 1. Sci. Adv. 2024, 10, eadn1524. [Google Scholar] [CrossRef]
  51. Luttens, A.; Vo, D.D.; Scaletti, E.R.; Wiita, E.; Almlöf, I.; Wallner, O.; Davies, J.; Košenina, S.; Meng, L.; Long, M.; et al. Virtual Fragment Screening for DNA Repair Inhibitors in Vast Chemical Space. Nat. Commun. 2025, 16, 1741. [Google Scholar] [CrossRef]
  52. Liu, F.; Wu, C.-G.; Tu, C.-L.; Glenn, I.; Meyerowitz, J.; Kaplan, A.L.; Lyu, J.; Cheng, Z.; Tarkhanova, O.O.; Moroz, Y.S.; et al. Large Library Docking Identifies Positive Allosteric Modulators of the Calcium-Sensing Receptor. Science 2024, 385, eado1868. [Google Scholar] [CrossRef] [PubMed]
  53. Everson, N.; Bach, J.; Hammill, J.T.; Falade, M.O.; Rice, A.L.; Guy, R.K.; Eagon, S. Identification of Plasmodium Falciparum Heat Shock 90 Inhibitors via Molecular Docking. Bioorg. Med. Chem. Lett. 2021, 35, 127818. [Google Scholar] [CrossRef]
  54. Sydow, D.; Morger, A.; Driller, M.; Volkamer, A. TeachOpenCADD: A Teaching Platform for Computer-Aided Drug Design Using Open Source Packages and Data. J. Cheminform. 2019, 11, 29. [Google Scholar] [CrossRef]
  55. Sydow, D.; Rodríguez-Guerra, J.; Kimber, T.B.; Schaller, D.; Taylor, C.J.; Chen, Y.; Leja, M.; Misra, S.; Wichmann, M.; Ariamajd, A.; et al. TeachOpenCADD 2022: Open Source and FAIR Python Pipelines to Assist in Structural Bioinformatics and Cheminformatics Research. Nucleic Acids Res. 2022, 50, W753–W760. [Google Scholar] [CrossRef]
  56. Clent, B.A.; Wang, Y.; Britton, H.C.; Otto, F.; Swain, C.J.; Todd, M.H.; Wilden, J.D.; Tabor, A.B. Molecular Docking with Open Access Software: Development of an Online Laboratory Handbook and Remote Workflow for Chemistry and Pharmacy Master’s Students to Undertake Computer-Aided Drug Design. J. Chem. Educ. 2021, 98, 2899–2905. [Google Scholar] [CrossRef]
  57. Almahmoud, S.A.; Mohammed, H.A.; Arfeen, M.; Hegazy, M.M.; Dhaked, D.K.; Srivastava, A.; Azam, F.; Khan, R.A. Modular Approach to In Silico Antiviral Multitargets Inhibitor: Molecular Dockings, Dynamics, Principal Component Analysis, Clustering, and Energy Landscape. ChemistrySelect 2026, 11, e05129. [Google Scholar] [CrossRef]
  58. Azam, F.; Almahmoud, S.A.; Ali, A.; Ali, A. Targeting Mitochondrial Drp1 Dynamics in Neurodegenerative Diseases: A Comprehensive Drug Design Approach Using AutoDock Vina-GPU, DFT, and Molecular Dynamics Simulations. ChemistrySelect 2025, 10, e202406041. [Google Scholar] [CrossRef]
  59. Kim, S.; Chen, J.; Cheng, T.; Gindulyte, A.; He, J.; He, S.; Li, Q.; Shoemaker, B.A.; Thiessen, P.A.; Yu, B.; et al. PubChem in 2021: New Data Content and Improved Web Interfaces. Nucleic Acids Res. 2021, 49, D1388–D1395. [Google Scholar] [CrossRef] [PubMed]
  60. Hu, Q.; Wang, Z.; Meng, J.; Li, W.; Guo, J.; Mu, Y.; Wang, S.; Zheng, L.; Wei, Y. OpenDock: A Pytorch-Based Open-Source Framework for Protein–Ligand Docking and Modelling. Bioinformatics 2024, 40, btae628. [Google Scholar] [CrossRef]
  61. Sharma, D.; Anabala, M.; Jain, V.V.; Shyam, M.; Prince, S.E.; Muniyan, R. Computational Landscape in Drug Discovery: From AI/ML Models to Translational Application. Scientifica 2025, 2025, 1688637. [Google Scholar] [CrossRef]
  62. Paggi, J.M.; Pandit, A.; Dror, R.O. The Art and Science of Molecular Docking. Annu. Rev. Biochem. 2024, 93, 389–410. [Google Scholar] [CrossRef] [PubMed]
  63. Pinzi, L.; Rastelli, G. Molecular Docking: Shifting Paradigms in Drug Discovery. Int. J. Mol. Sci. 2019, 20. [Google Scholar] [CrossRef]
  64. Sliwoski, G.; Kothiwale, S.; Meiler, J.; Lowe, E.W.J. Computational Methods in Drug Discovery. Pharmacol. Rev. 2014, 66, 334–395. [Google Scholar] [CrossRef]
  65. Mysinger, M.M.; Carchia, M.; Irwin, J.J.; Shoichet, B.K. Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking. J. Med. Chem. 2012, 55, 6582–6594. [Google Scholar] [CrossRef]
  66. Truchon, J.-F.; Bayly, C.I. Evaluating Virtual Screening Methods: Good and Bad Metrics for the “Early Recognition” Problem. J. Chem. Inf. Model. 2007, 47, 488–508. [Google Scholar] [CrossRef]
  67. Jumper, J.; Evans, R.; Pritzel, A.; Green, T.; Figurnov, M.; Ronneberger, O.; Tunyasuvunakool, K.; Bates, R.; Žídek, A.; Potapenko, A.; et al. Highly Accurate Protein Structure Prediction with AlphaFold. Nature 2021, 596, 583–589. [Google Scholar] [CrossRef]
  68. Harding, M.M. The Architecture of Metal Coordination Groups in Proteins. Acta Crystallogr. D Biol. Crystallogr. 2004, 60, 849–859. [Google Scholar] [CrossRef] [PubMed]
  69. Spyrakis, F.; Cavasotto, C.N. Open Challenges in Structure-Based Virtual Screening: Receptor Modeling, Target Flexibility Consideration and Active Site Water Molecules Description. Arch. Biochem. Biophys. 2015, 583, 105–119. [Google Scholar] [CrossRef] [PubMed]
  70. Forli, S. Charting a Path to Success in Virtual Screening. Molecules 2015, 20, 18732–18758. [Google Scholar] [CrossRef]
  71. Hassan, N.M.; Alhossary, A.A.; Mu, Y.; Kwoh, C.-K. Protein-Ligand Blind Docking Using QuickVina-W with Inter-Process Spatio-Temporal Integration. Sci. Rep. 2017, 7, 15451. [Google Scholar] [CrossRef]
  72. Roomi, M.S.; Culletta, G.; Longo, L.; Filgueira de Azevedo, W.; Perricone, U.; Tutone, M. Docking in the Dark: Insights into Protein–Protein and Protein–Ligand Blind Docking. Pharmaceuticals 2025, 18, 1777. [Google Scholar] [CrossRef] [PubMed]
  73. Hetényi, C.; van der Spoel, D. Blind Docking of Drug-Sized Compounds to Proteins with up to a Thousand Residues. FEBS Lett. 2006, 580, 1447–1450. [Google Scholar] [CrossRef] [PubMed]
  74. Azam, F.; Eid, E.E.M.; Almutairi, A. Targeting SARS-CoV-2 Main Protease by Teicoplanin: A Mechanistic Insight by Docking, MM/GBSA and Molecular Dynamics Simulation. J. Mol. Struct. 2021, 1246, 131124. [Google Scholar] [CrossRef]
  75. Payandeh, J.; Volgraf, M. Ligand Binding at the Protein-Lipid Interface: Strategic Considerations for Drug Design. Nat. Rev. Drug Discov. 2021, 20, 710–722. [Google Scholar] [CrossRef]
  76. Wang, Y.; Yu, Z.; Xiao, W.; Lu, S.; Zhang, J. Allosteric Binding Sites at the Receptor-Lipid Bilayer Interface: Novel Targets for GPCR Drug Discovery. Drug Discov. Today 2021, 26, 690–703. [Google Scholar] [CrossRef]
  77. Barkdull, A.P.; Holcomb, M.; Forli, S. A Quantitative Analysis of Ligand Binding at the Protein-Lipid Bilayer Interface. Commun. Chem. 2025, 8, 89. [Google Scholar] [CrossRef]
  78. Zhang, D.; Gao, Z.-G.; Zhang, K.; Kiselev, E.; Crane, S.; Wang, J.; Paoletta, S.; Yi, C.; Ma, L.; Zhang, W.; et al. Two Disparate Ligand-Binding Sites in the Human P2Y1 Receptor. Nature 2015, 520, 317–321. [Google Scholar] [CrossRef]
  79. Coleman, J.A.; Green, E.M.; Gouaux, E. X-Ray Structures and Mechanism of the Human Serotonin Transporter. Nature 2016, 532, 334–339. [Google Scholar] [CrossRef] [PubMed]
  80. Robertson, N.; Rappas, M.; Doré, A.S.; Brown, J.; Bottegoni, G.; Koglin, M.; Cansfield, J.; Jazayeri, A.; Cooke, R.M.; Marshall, F.H. Structure of the Complement C5a Receptor Bound to the Extra-Helical Antagonist NDT9513727. Nature 2018, 553, 111–114. [Google Scholar] [CrossRef]
  81. Shulga, D.A.; Kudryavtsev, K. V Ensemble Docking as a Tool for the Rational Design of Peptidomimetic Staphylococcus aureus Sortase A Inhibitors. Int. J. Mol. Sci. 2024, 25, 11279. [Google Scholar] [CrossRef]
  82. Dhar, A.; Sisk, T.R.; Robustelli, P. Ensemble Docking for Intrinsically Disordered Proteins. J. Chem. Inf. Model. 2025, 65, 6847–6860. [Google Scholar] [CrossRef]
  83. Zhu, K.; Li, C.; Wu, K.Y.; Mohr, C.; Li, X.; Lanman, B. Modeling Receptor Flexibility in the Structure-Based Design of KRASG12C Inhibitors. J. Comput. Aided Mol. Des. 2022, 36, 591–604. [Google Scholar] [CrossRef]
  84. Kamenik, A.S.; Singh, I.; Lak, P.; Balius, T.E.; Liedl, K.R.; Shoichet, B.K. Energy Penalties Enhance Flexible Receptor Docking in a Model Cavity. Proc. Natl. Acad. Sci. USA 2021, 118, e2106195118. [Google Scholar] [CrossRef] [PubMed]
  85. Morris, G.M.; Huey, R.; Lindstrom, W.; Sanner, M.F.; Belew, R.K.; Goodsell, D.S.; Olson, A.J. AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility. J. Comput. Chem. 2009, 30, 2785–2791. [Google Scholar] [CrossRef] [PubMed]
  86. Scarpino, A.; Petri, L.; Knez, D.; Imre, T.; Ábrányi-Balogh, P.; Ferenczy, G.G.; Gobec, S.; Keserű, G.M. WIDOCK: A Reactive Docking Protocol for Virtual Screening of Covalent Inhibitors. J. Comput. Aided Mol. Des. 2021, 35, 223–244. [Google Scholar] [CrossRef]
  87. London, N.; Miller, R.M.; Krishnan, S.; Uchida, K.; Irwin, J.J.; Eidam, O.; Gibold, L.; Cimermančič, P.; Bonnet, R.; Shoichet, B.K.; et al. Covalent Docking of Large Libraries for the Discovery of Chemical Probes. Nat. Chem. Biol. 2014, 10, 1066–1072, Erratum in Nat. Chem. Biol. 2015, 11, 235. https://doi.org/10.1038/nchembio0315-235b. [Google Scholar] [CrossRef]
  88. Singh, N.; Vayer, P.; Villoutreix, B.O. The Covalent Docking Software Landscape: Features and Applications in Drug Design. Brief. Bioinform. 2025, 26, bbaf697. [Google Scholar] [CrossRef]
  89. Kumalo, H.M.; Bhakat, S.; Soliman, M.E.S. Theory and Applications of Covalent Docking in Drug Discovery: Merits and Pitfalls. Molecules 2015, 20, 1984–2000. [Google Scholar] [CrossRef]
  90. Sastry, G.M.; Adzhigirey, M.; Day, T.; Annabhimoju, R.; Sherman, W. Protein and Ligand Preparation: Parameters, Protocols, and Influence on Virtual Screening Enrichments. J. Comput. Aided Mol. Des. 2013, 27, 221–234. [Google Scholar] [CrossRef] [PubMed]
  91. Holcomb, M.; Chang, Y.-T.; Goodsell, D.S.; Forli, S. Evaluation of AlphaFold2 Structures as Docking Targets. Protein Sci. 2023, 32, e4530. [Google Scholar] [CrossRef] [PubMed]
  92. Scardino, V.; Di Filippo, J.I.; Cavasotto, C.N. How Good Are AlphaFold Models for Docking-Based Virtual Screening? iScience 2023, 26, 105920. [Google Scholar] [CrossRef]
  93. Díaz-Rovira, A.M.; Martín, H.; Beuming, T.; Díaz, L.; Guallar, V.; Ray, S.S. Are Deep Learning Structural Models Sufficiently Accurate for Virtual Screening? Application of Docking Algorithms to AlphaFold2 Predicted Structures. J. Chem. Inf. Model. 2023, 63, 1668–1674. [Google Scholar] [CrossRef]
  94. ten Brink, T.; Exner, T.E. Influence of Protonation, Tautomeric, and Stereoisomeric States on Protein−Ligand Docking Results. J. Chem. Inf. Model. 2009, 49, 1535–1546. [Google Scholar] [CrossRef]
  95. O’Boyle, N.M.; Banck, M.; James, C.A.; Morley, C.; Vandermeersch, T.; Hutchison, G.R. Open Babel: An Open Chemical Toolbox. J. Cheminform. 2011, 3, 33. [Google Scholar] [CrossRef] [PubMed]
  96. Ropp, P.J.; Spiegel, J.O.; Walker, J.L.; Green, H.; Morales, G.A.; Milliken, K.A.; Ringe, J.J.; Durrant, J.D. Gypsum-DL: An Open-Source Program for Preparing Small-Molecule Libraries for Structure-Based Virtual Screening. J. Cheminform. 2019, 11, 34. [Google Scholar] [CrossRef]
  97. Santos-Martins, D.; He, Y.; Eberhardt, J.; Sharma, P.; Bruciaferri, N.; Holcomb, M.; Llanos, M.A.; Hansel-Harris, A.; Barkdull, A.P.; Tillack, A.F.; et al. Meeko: Molecule Parametrization and Software Interoperability for Docking and Beyond. J. Chem. Inf. Model. 2025, 65, 13045–13050. [Google Scholar] [CrossRef]
  98. Ravindranath, P.A.; Sanner, M.F. AutoSite: An Automated Approach for Pseudo-Ligands Prediction—From Ligand-Binding Sites Identification to Predicting Key Ligand Atoms. Bioinformatics 2016, 32, 3142–3149. [Google Scholar] [CrossRef] [PubMed]
  99. Durrant, J.D.; McCammon, J.A. BINANA: A Novel Algorithm for Ligand-Binding Characterization. J. Mol. Graph. Model. 2011, 29, 888–893. [Google Scholar] [CrossRef] [PubMed]
  100. Aggarwal, R.; Gupta, A.; Chelur, V.; Jawahar, C.V.; Priyakumar, U.D. DeepPocket: Ligand Binding Site Detection and Segmentation Using 3D Convolutional Neural Networks. J. Chem. Inf. Model. 2022, 62, 5069–5079. [Google Scholar] [CrossRef] [PubMed]
  101. Ropp, P.J.; Kaminsky, J.C.; Yablonski, S.; Durrant, J.D. Dimorphite-DL: An Open-Source Program for Enumerating the Ionization States of Drug-like Small Molecules. J. Cheminform. 2019, 11, 14. [Google Scholar] [CrossRef]
  102. Bell, E.W.; Zhang, Y. DockRMSD: An Open-Source Tool for Atom Mapping and RMSD Calculation of Symmetric Molecules through Graph Isomorphism. J. Cheminform. 2019, 11, 40. [Google Scholar] [CrossRef]
  103. Le Guilloux, V.; Schmidtke, P.; Tuffery, P. Fpocket: An Open Source Platform for Ligand Pocket Detection. BMC Bioinform. 2009, 10, 168. [Google Scholar] [CrossRef]
  104. Davis, I.W.; Leaver-Fay, A.; Chen, V.B.; Block, J.N.; Kapral, G.J.; Wang, X.; Murray, L.W.; Arendall, W.B., 3rd; Snoeyink, J.; Richardson, J.S.; et al. MolProbity: All-Atom Contacts and Structure Validation for Proteins and Nucleic Acids. Nucleic Acids Res. 2007, 35, W375–W383. [Google Scholar] [CrossRef]
  105. Wójcikowski, M.; Zielenkiewicz, P.; Siedlecki, P. Open Drug Discovery Toolkit (ODDT): A New Open-Source Player in the Drug Discovery Field. J. Cheminform. 2015, 7, 26. [Google Scholar] [CrossRef]
  106. Polák, L.; Škoda, P.; Riedlová, K.; Krivák, R.; Novotný, M.; Hoksza, D. PrankWeb 4: A Modular Web Server for Protein–Ligand Binding Site Prediction and Downstream Analysis. Nucleic Acids Res. 2025, 53, W466–W471. [Google Scholar] [CrossRef] [PubMed]
  107. Krivák, R.; Hoksza, D. P2Rank: Machine Learning Based Tool for Rapid and Accurate Prediction of Ligand Binding Sites from Protein Structure. J. Cheminform. 2018, 10, 39. [Google Scholar] [CrossRef] [PubMed]
  108. Carbone, J.; Ghidini, A.; Romano, A.; Gentilucci, L.; Musiani, F. PacDOCK: A Web Server for Positional Distance-Based and Interaction-Based Analysis of Docking Results. Molecules 2022, 27, 6884. [Google Scholar] [CrossRef]
  109. Dolinsky, T.J.; Czodrowski, P.; Li, H.; Nielsen, J.E.; Jensen, J.H.; Klebe, G.; Baker, N.A. PDB2PQR: Expanding and Upgrading Automated Preparation of Biomolecular Structures for Molecular Simulations. Nucleic Acids Res. 2007, 35, W522–W525. [Google Scholar] [CrossRef]
  110. Eastman, P.; Swails, J.; Chodera, J.D.; McGibbon, R.T.; Zhao, Y.; Beauchamp, K.A.; Wang, L.-P.; Simmonett, A.C.; Harrigan, M.P.; Stern, C.D.; et al. OpenMM 7: Rapid Development of High Performance Algorithms for Molecular Dynamics. PLoS Comput. Biol. 2017, 13, e1005659. [Google Scholar] [CrossRef]
  111. Rodrigues, J.; Teixeira, J.M.C.; Trellet, M.; Bonvin, A. Pdb-Tools: A Swiss Army Knife for Molecular Structures; Version 1, Peer Review: 2 Approved; F1000Research Ltd.: London, UK, 2018; Volume 7. [Google Scholar] [CrossRef]
  112. Schake, P.; Bolz, S.N.; Linnemann, K.; Schroeder, M. PLIP 2025: Introducing Protein–Protein Interactions to the Protein–Ligand Interaction Profiler. Nucleic Acids Res. 2025, 53, W463–W465. [Google Scholar] [CrossRef]
  113. Buttenschoen, M.; Morris, G.M.; Deane, C.M. PoseBusters: AI-Based Docking Methods Fail to Generate Physically Valid Poses or Generalise to Novel Sequences. Chem. Sci. 2024, 15, 3130–3139. [Google Scholar] [CrossRef]
  114. Harris, C.; Didi, K.; Jamasb, A.R.; Joshi, C.K.; Mathis, S.V.; Lio, P.; Blundell, T. Benchmarking Generated Poses: How Rational Is Structure-Based Drug Design with Generative Models? arXiv 2023, arXiv:2308.07413. [Google Scholar] [CrossRef]
  115. Lomize, M.A.; Pogozheva, I.D.; Joo, H.; Mosberg, H.I.; Lomize, A.L. OPM Database and PPM Web Server: Resources for Positioning of Proteins in Membranes. Nucleic Acids Res. 2012, 40, D370–D376. [Google Scholar] [CrossRef] [PubMed]
  116. Bouysset, C.; Fiorucci, S. ProLIF: A Library to Encode Molecular Interactions as Fingerprints. J. Cheminform. 2021, 13, 72. [Google Scholar] [CrossRef]
  117. Hansel-Harris, A.T.; Santos-Martins, D.; Bruciaferri, N.; Tillack, A.F.; Holcomb, M.; Forli, S. Ringtail: A Python Tool for Efficient Management and Storage of Virtual Screening Results. J. Chem. Inf. Model. 2023, 63, 1858–1864. [Google Scholar] [CrossRef]
  118. Meli, R.; Biggin, P.C. Spyrmsd: Symmetry-Corrected RMSD Calculations in Python. J. Cheminform. 2020, 12, 49. [Google Scholar] [CrossRef] [PubMed]
  119. Giulini, M.; Reys, V.; Teixeira, J.M.C.; Jiménez-García, B.; Honorato, R.V.; Kravchenko, A.; Xu, X.; Versini, R.; Engel, A.; Verhoeven, S.; et al. HADDOCK3: A Modular and Versatile Platform for Integrative Modeling of Biomolecular Complexes. J. Chem. Inf. Model. 2025, 65, 7315–7324. [Google Scholar] [CrossRef] [PubMed]
  120. Dominguez, C.; Boelens, R.; Bonvin, A.M.J.J. HADDOCK:  A Protein−Protein Docking Approach Based on Biochemical or Biophysical Information. J. Am. Chem. Soc. 2003, 125, 1731–1737. [Google Scholar] [CrossRef]
  121. Kozakov, D.; Hall, D.R.; Xia, B.; Porter, K.A.; Padhorny, D.; Yueh, C.; Beglov, D.; Vajda, S. The ClusPro Web Server for Protein–Protein Docking. Nat. Protoc. 2017, 12, 255–278. [Google Scholar] [CrossRef]
  122. Raveh, B.; London, N.; Zimmerman, L.; Schueler-Furman, O. Rosetta FlexPepDock Ab-Initio: Simultaneous Folding, Docking and Refinement of Peptides onto Their Receptors. PLoS ONE 2011, 6, e18934. [Google Scholar] [CrossRef]
  123. Tuszynska, I.; Magnus, M.; Jonak, K.; Dawson, W.; Bujnicki, J.M. NPDock: A Web Server for Protein–Nucleic Acid Docking. Nucleic Acids Res. 2015, 43, W425–W430. [Google Scholar] [CrossRef]
  124. Gromiha, M.M.; Harini, K. Protein-Nucleic Acid Complexes: Docking and Binding Affinity. Curr. Opin. Struct. Biol. 2025, 90, 102955. [Google Scholar] [CrossRef] [PubMed]
  125. Jiménez-García, B.; Roel-Touris, J.; Barradas-Bautista, D. The LightDock Server: Artificial Intelligence-Powered Modeling of Macromolecular Interactions. Nucleic Acids Res. 2023, 51, W298–W304. [Google Scholar] [CrossRef]
  126. Burger, W.A.C.; Mobbs, J.I.; Rana, B.; Wang, J.; Joshi, K.; Gentry, P.R.; Yeasmin, M.; Venugopal, H.; Bender, A.M.; Lindsley, C.W.; et al. Cryo-EM Reveals an Extrahelical Allosteric Binding Site at the M5 MAChR. Nat. Commun. 2025, 16, 7046. [Google Scholar] [CrossRef]
  127. Obi, P.; Natesan, S. Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs. J. Med. Chem. 2022, 65, 12240–12255. [Google Scholar] [CrossRef]
  128. Valdés-Tresanco, M.S.; Valdés-Tresanco, M.E.; Valiente, P.A.; Moreno, E. AMDock: A Versatile Graphical Tool for Assisting Molecular Docking with Autodock Vina and Autodock4. Biol. Direct 2020, 15, 12. [Google Scholar] [CrossRef]
  129. de Vries, S.; Zacharias, M. Flexible Docking and Refinement with a Coarse-Grained Protein Model Using ATTRACT. Proteins 2013, 81, 2167–2174. [Google Scholar] [CrossRef]
  130. Zacharias, M. ATTRACT: Protein-Protein Docking in CAPRI Using a Reduced Protein Model. Proteins 2005, 60, 252–256. [Google Scholar] [CrossRef]
  131. Podtelezhnikov, A.A.; Wild, D.L. CRANKITE: A Fast Polypeptide Backbone Conformation Sampler. Source Code Biol. Med. 2008, 3, 12. [Google Scholar] [CrossRef]
  132. Eberhardt, J.; Santos-Martins, D.; Tillack, A.F.; Forli, S. AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. J. Chem. Inf. Model. 2021, 61, 3891–3898. [Google Scholar] [CrossRef]
  133. Ravindranath, P.A.; Forli, S.; Goodsell, D.S.; Olson, A.J.; Sanner, M.F. AutoDockFR: Advances in Protein-Ligand Docking with Explicitly Specified Binding Site Flexibility. PLoS Comput. Biol. 2015, 11, e1004586. [Google Scholar] [CrossRef] [PubMed]
  134. Zhao, Y.; Stoffler, D.; Sanner, M. Hierarchical and Multi-Resolution Representation of Protein Flexibility. Bioinformatics 2006, 22, 2768–2774. [Google Scholar] [CrossRef] [PubMed]
  135. Santos-Martins, D.; Solis-Vasquez, L.; Tillack, A.F.; Sanner, M.F.; Koch, A.; Forli, S. Accelerating AutoDock4 with GPUs and Gradient-Based Local Search. J. Chem. Theory Comput. 2021, 17, 1060–1073. [Google Scholar] [CrossRef] [PubMed]
  136. Bickel, J.D.; Boysan, B.T.; Rizzo, R.C. Fragment and Torsion Biasing Algorithms for Construction of Small Organic Molecules in Proteins Using DOCK. J. Comput. Chem. 2025, 46, e27508. [Google Scholar] [CrossRef]
  137. Du, L.; Geng, C.; Zeng, Q.; Huang, T.; Tang, J.; Chu, Y.; Zhao, K. Dockey: A Modern Integrated Tool for Large-Scale Molecular Docking and Virtual Screening. Brief. Bioinform. 2023, 24, bbad047. [Google Scholar] [CrossRef]
  138. Rosignoli, S.; Paiardini, A. DockingPie: A Consensus Docking Plugin for PyMOL. Bioinformatics 2022, 38, 4233–4234. [Google Scholar] [CrossRef] [PubMed]
  139. Bullock, C.W.; Jacob, R.B.; McDougal, O.M.; Hampikian, G.; Andersen, T. Dockomatic—Automated Ligand Creation and Docking. BMC Res. Notes 2010, 3, 289. [Google Scholar] [CrossRef]
  140. Jacob, R.B.; Bullock, C.W.; Andersen, T.; McDougal, O.M. DockoMatic: Automated Peptide Analog Creation for High Throughput Virtual Screening. J. Comput. Chem. 2011, 32, 2936–2941. [Google Scholar] [CrossRef]
  141. Bullock, C.; Cornia, N.; Jacob, R.; Remm, A.; Peavey, T.; Weekes, K.; Mallory, C.; Oxford, J.T.; McDougal, O.M.; Andersen, T.L. DockoMatic 2.0: High Throughput Inverse Virtual Screening and Homology Modeling. J. Chem. Inf. Model. 2013, 53, 2161–2170. [Google Scholar] [CrossRef]
  142. Morency, L.-P.; Gaudreault, F.; Najmanovich, R. Applications of the NRGsuite and the Molecular Docking Software FlexAID in Computational Drug Discovery and Design. Methods Mol. Biol. 2018, 1762, 367–388. [Google Scholar] [CrossRef]
  143. Li, H.; Leung, K.-S.; Wong, M.-H. Idock: A Multithreaded Virtual Screening Tool for Flexible Ligand Docking. In Proceedings of the 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), San Diego, CA, USA, 9–12 May 2012; IEEE: New York, NY, USA; pp. 77–84.
  144. Roel-Touris, J.; Bonvin, A.M.J.J.; Jiménez-García, B. LightDock Goes Information-Driven. Bioinformatics 2020, 36, 950–952. [Google Scholar] [CrossRef]
  145. Jiménez-García, B.; Roel-Touris, J.; Romero-Durana, M.; Vidal, M.; Jiménez-González, D.; Fernández-Recio, J. LightDock: A New Multi-Scale Approach to Protein–Protein Docking. Bioinformatics 2018, 34, 49–55. [Google Scholar] [CrossRef] [PubMed]
  146. Hakkennes, M.L.A.; Buda, F.; Bonnet, S. MetalDock: An Open Access Docking Tool for Easy and Reproducible Docking of Metal Complexes. J. Chem. Inf. Model. 2023, 63, 7816–7825. [Google Scholar] [CrossRef] [PubMed]
  147. Kabier, M.; Gambacorta, N.; Trisciuzzi, D.; Kumar, S.; Nicolotti, O.; Mathew, B. MzDOCK: A Free Ready-to-Use GUI-Based Pipeline for Molecular Docking Simulations. J. Comput. Chem. 2024, 45, 1980–1986. [Google Scholar] [CrossRef]
  148. DISI. DOCK3.8:Pydock3; DISI: San Francisco, CA, USA, 2023. [Google Scholar]
  149. Dallakyan, S.; Olson, A.J. Small-Molecule Library Screening by Docking with PyRx BT—Chemical Biology: Methods and Protocols; Hempel, J.E., Williams, C.H., Hong, C.C., Eds.; Springer: New York, NY, USA, 2015; pp. 243–250. [Google Scholar]
  150. Alhossary, A.; Handoko, S.D.; Mu, Y.; Kwoh, C.-K. Fast, Accurate, and Reliable Molecular Docking with QuickVina 2. Bioinformatics 2015, 31, 2214–2216. [Google Scholar] [CrossRef] [PubMed]
  151. Ruiz-Carmona, S.; Alvarez-Garcia, D.; Foloppe, N.; Garmendia-Doval, A.B.; Juhos, S.; Schmidtke, P.; Barril, X.; Hubbard, R.E.; Morley, S.D. RDock: A Fast, Versatile and Open Source Program for Docking Ligands to Proteins and Nucleic Acids. PLoS Comput. Biol. 2014, 10, e1003571. [Google Scholar] [CrossRef]
  152. Majeux, N.; Scarsi, M.; Apostolakis, J.; Ehrhardt, C.; Caflisch, A. Exhaustive Docking of Molecular Fragments with Electrostatic Solvation. Proteins Struct. Funct. Bioinform. 1999, 37, 88–105. [Google Scholar] [CrossRef]
  153. Koes, D.R.; Baumgartner, M.P.; Camacho, C.J. Lessons Learned in Empirical Scoring with Smina from the CSAR 2011 Benchmarking Exercise. J. Chem. Inf. Model. 2013, 53, 1893–1904. [Google Scholar] [CrossRef] [PubMed]
  154. Yu, Y.; Cai, C.; Wang, J.; Bo, Z.; Zhu, Z.; Zheng, H. Uni-Dock: GPU-Accelerated Docking Enables Ultralarge Virtual Screening. J. Chem. Theory Comput. 2023, 19, 3336–3345. [Google Scholar] [CrossRef] [PubMed]
  155. Nivedha, A.K.; Thieker, D.F.; Hu, H.; Woods, R.J. Vina-Carb: Improving Glycosidic Angles during Carbohydrate Docking. J. Chem. Theory Comput. 2016, 12, 892–901. [Google Scholar] [CrossRef]
  156. Ding, J.; Tang, S.; Mei, Z.; Wang, L.; Huang, Q.; Hu, H.; Ling, M.; Wu, J. Vina-GPU 2.0: Further Accelerating AutoDock Vina and Its Derivatives with Graphics Processing Units. J. Chem. Inf. Model. 2023, 63, 1982–1998. [Google Scholar] [CrossRef]
  157. Tang, S.; Chen, R.; Lin, M.; Lin, Q.; Zhu, Y.; Ding, J.; Hu, H.; Ling, M.; Wu, J. Accelerating AutoDock Vina with GPUs. Molecules 2022, 27, 3041. [Google Scholar] [CrossRef]
  158. Tang, S.; Ding, J.; Zhu, X.; Wang, Z.; Zhao, H.; Wu, J. Vina-GPU 2.1: Towards Further Optimizing Docking Speed and Precision of AutoDock Vina and Its Derivatives. IEEE/ACM Trans. Comput. Biol. Bioinform. 2024, 21, 2382–2393. [Google Scholar] [CrossRef]
  159. Koebel, M.R.; Schmadeke, G.; Posner, R.G.; Sirimulla, S. AutoDock VinaXB: Implementation of XBSF, New Empirical Halogen Bond Scoring Function, into AutoDock Vina. J. Cheminform. 2016, 8, 27. [Google Scholar] [CrossRef]
  160. Kurcinski, M.; Jamroz, M.; Blaszczyk, M.; Kolinski, A.; Kmiecik, S. CABS-Dock Web Server for the Flexible Docking of Peptides to Proteins without Prior Knowledge of the Binding Site. Nucleic Acids Res. 2015, 43, W419–W424. [Google Scholar] [CrossRef]
  161. Ashizawa, R.; Kotelnikov, S.; Khan, O.; Li, S.X.; Glukhov, E.; Cao, X.; Lazou, M.; Bekar-Cesaretli, A.; Hailegeorgis, D.; Averkava, V.; et al. Modeling Protein–Protein and Protein–Ligand Interactions by the ClusPro Team in CASP16. Proteins Struct. Funct. Bioinform. 2026, 94, 183–191. [Google Scholar] [CrossRef]
  162. Conev, A.; Rigo, M.M.; Devaurs, D.; Fonseca, A.F.; Kalavadwala, H.; de Freitas, M.V.; Clementi, C.; Zanatta, G.; Antunes, D.A.; Kavraki, L.E. EnGens: A Computational Framework for Generation and Analysis of Representative Protein Conformational Ensembles. Brief. Bioinform. 2023, 24, bbad242. [Google Scholar] [CrossRef]
  163. Conev, A.; Chen, J.; Kavraki, L.E. DINC-Ensemble: A Web Server for Docking Large Ligands Incrementally to an Ensemble of Receptor Conformations. J. Mol. Biol. 2025, 437, 169163. [Google Scholar] [CrossRef]
  164. Guedes, I.A.; Pereira da Silva, M.M.; Galheigo, M.; Krempser, E.; de Magalhães, C.S.; Correa Barbosa, H.J.; Dardenne, L.E. DockThor-VS: A Free Platform for Receptor-Ligand Virtual Screening. J. Mol. Biol. 2024, 436, 168548. [Google Scholar] [CrossRef] [PubMed]
  165. Zhang, W.; Bell, E.W.; Yin, M.; Zhang, Y. EDock: Blind Protein–Ligand Docking by Replica-Exchange Monte Carlo Simulation. J. Cheminform. 2020, 12, 37. [Google Scholar] [CrossRef]
  166. Lee, C.; Won, J.; Ryu, S.; Yang, J.; Jung, N.; Park, H.; Seok, C. GalaxyDock-DL: Protein–Ligand Docking by Global Optimization and Neural Network Energy. J. Chem. Theory Comput. 2024, 20, 7370–7382. [Google Scholar] [CrossRef] [PubMed]
  167. Ko, J.; Park, H.; Heo, L.; Seok, C. GalaxyWEB Server for Protein Structure Prediction and Refinement. Nucleic Acids Res. 2012, 40, W294–W297. [Google Scholar] [CrossRef] [PubMed]
  168. Shin, W.-H.; Kim, J.-K.; Kim, D.-S.; Seok, C. GalaxyDock2: Protein–Ligand Docking Using Beta-Complex and Global Optimization. J. Comput. Chem. 2013, 34, 2647–2656. [Google Scholar] [CrossRef] [PubMed]
  169. Heo, L.; Shin, W.-H.; Lee, M.S.; Seok, C. GalaxySite: Ligand-Binding-Site Prediction by Using Molecular Docking. Nucleic Acids Res. 2014, 42, W210–W214. [Google Scholar] [CrossRef]
  170. Park, S.; Seok, C. GalaxyWater-CNN: Prediction of Water Positions on the Protein Structure by a 3D-Convolutional Neural Network. J. Chem. Inf. Model. 2022, 62, 3157–3168. [Google Scholar] [CrossRef] [PubMed]
  171. Choi, J.; Park, T.; Yul Lee, S.; Yang, J.; Seok, C. GalaxyDomDock: An Ab Initio Domain-Domain Docking Web Server for Multi-Domain Protein Structure Prediction. J. Mol. Biol. 2022, 434, 167508. [Google Scholar] [CrossRef]
  172. Park, T.; Won, J.; Baek, M.; Seok, C. GalaxyHeteromer: Protein Heterodimer Structure Prediction by Template-Based and Ab Initio Docking. Nucleic Acids Res. 2021, 49, W237–W241. [Google Scholar] [CrossRef]
  173. Lee, G.R.; Seok, C. Galaxy7TM: Flexible GPCR–Ligand Docking by Structure Refinement. Nucleic Acids Res. 2016, 44, W502–W506. [Google Scholar] [CrossRef]
  174. Lee, H.; Heo, L.; Lee, M.S.; Seok, C. GalaxyPepDock: A Protein-Peptide Docking Tool Based on Interaction Similarity and Energy Optimization. Nucleic Acids Res. 2015, 43, W431–W435. [Google Scholar] [CrossRef] [PubMed]
  175. Yang, J.; Baek, M.; Seok, C. GalaxyDock3: Protein-Ligand Docking That Considers the Full Ligand Conformational Flexibility. J. Comput. Chem. 2019, 40, 2739–2748. [Google Scholar] [CrossRef] [PubMed]
  176. Singh, A.; Copeland, M.M.; Kundrotas, P.J.; Vakser, I.A. GRAMM Web Server for Protein Docking. In Computational Drug Discovery and Design; Gore, M., Jagtap, U.B., Eds.; Springer: New York, NY, USA, 2024; pp. 101–112. ISBN 978-1-0716-3441-7. [Google Scholar]
  177. Honorato, R.V.; Koukos, P.I.; Jiménez-García, B.; Tsaregorodtsev, A.; Verlato, M.; Giachetti, A.; Rosato, A.; Bonvin, A.M.J.J. Structural Biology in the Clouds: The WeNMR-EOSC Ecosystem. Front. Mol. Biosci. 2021, 8, 729513. [Google Scholar] [CrossRef]
  178. Honorato, R.V.; Trellet, M.E.; Jiménez-García, B.; Schaarschmidt, J.J.; Giulini, M.; Reys, V.; Koukos, P.I.; Rodrigues, J.P.G.L.M.; Karaca, E.; van Zundert, G.C.P.; et al. The HADDOCK2.4 Web Server for Integrative Modeling of Biomolecular Complexes. Nat. Protoc. 2024, 19, 3219–3241. [Google Scholar] [CrossRef]
  179. Weng, G.; Wang, E.; Wang, Z.; Liu, H.; Zhu, F.; Li, D.; Hou, T. HawkDock: A Web Server to Predict and Analyze the Protein–Protein Complex Based on Computational Docking and MM/GBSA. Nucleic Acids Res. 2019, 47, W322–W330. [Google Scholar] [CrossRef]
  180. Li, H.; Huang, E.; Zhang, Y.; Huang, S.-Y.; Xiao, Y. HDOCK Update for Modeling Protein-RNA/DNA Complex Structures. Protein Sci. 2022, 31, e4441. [Google Scholar] [CrossRef]
  181. Yan, Y.; Tao, H.; He, J.; Huang, S.-Y. The HDOCK Server for Integrated Protein–Protein Docking. Nat. Protoc. 2020, 15, 1829–1852. [Google Scholar] [CrossRef] [PubMed]
  182. Yan, Y.; Zhang, D.; Zhou, P.; Li, B.; Huang, S.-Y. HDOCK: A Web Server for Protein–Protein and Protein–DNA/RNA Docking Based on a Hybrid Strategy. Nucleic Acids Res. 2017, 45, W365–W373. [Google Scholar] [CrossRef]
  183. Zhou, P.; Jin, B.; Li, H.; Huang, S.-Y. HPEPDOCK: A Web Server for Blind Peptide-Protein Docking Based on a Hierarchical Algorithm. Nucleic Acids Res. 2018, 46, W443–W450. [Google Scholar] [CrossRef]
  184. Kochnev, Y.; Ahmed, M.; Maldonado, A.M.; Durrant, J.D. MolModa: Accessible and Secure Molecular Docking in a Web Browser. Nucleic Acids Res. 2024, 52, W498–W506. [Google Scholar] [CrossRef]
  185. Labbé, C.M.; Rey, J.; Lagorce, D.; Vavruša, M.; Becot, J.; Sperandio, O.; Villoutreix, B.O.; Tufféry, P.; Miteva, M.A. MTiOpenScreen: A Web Server for Structure-Based Virtual Screening. Nucleic Acids Res. 2015, 43, W448–W454. [Google Scholar] [CrossRef]
  186. Ehrt, C.; Schulze, T.; Graef, J.; Diedrich, K.; Pletzer-Zelgert, J.; Rarey, M. ProteinsPlus: A Publicly Available Resource for Protein Structure Mining. Nucleic Acids Res. 2025, 53, W478–W484. [Google Scholar] [CrossRef]
  187. Rodríguez-Lumbreras, L.A.; Jiménez-García, B.; Giménez-Santamarina, S.; Fernández-Recio, J. PyDockDNA: A New Web Server for Energy-Based Protein-DNA Docking and Scoring. Front. Mol. Biosci. 2022, 9, 88996. [Google Scholar] [CrossRef]
  188. Jiménez-García, B.; Pons, C.; Fernández-Recio, J. PyDockWEB: A Web Server for Rigid-Body Protein-Protein Docking Using Electrostatics and Desolvation Scoring. Bioinformatics 2013, 29, 1698–1699. [Google Scholar] [CrossRef] [PubMed]
  189. Lyskov, S.; Chou, F.-C.; Conchúir, S.Ó.; Der, B.S.; Drew, K.; Kuroda, D.; Xu, J.; Weitzner, B.D.; Renfrew, P.D.; Sripakdeevong, P.; et al. Serverification of Molecular Modeling Applications: The Rosetta Online Server That Includes Everyone (ROSIE). PLoS ONE 2013, 8, e63906. [Google Scholar] [CrossRef] [PubMed]
  190. Moretti, R.; Lyskov, S.; Das, R.; Meiler, J.; Gray, J.J. Web-Accessible Molecular Modeling with Rosetta: The Rosetta Online Server That Includes Everyone (ROSIE). Protein Sci. 2018, 27, 259–268. [Google Scholar] [CrossRef] [PubMed]
  191. Tufféry, P.; Murail, S. Samuelmurail/Docking_py: Docking_py, a Python Library for Ligand Protein Docking; Zenodo: Paris, France, 2020. [Google Scholar]
  192. Mo, Q.; Xu, Z.; Yan, H.; Chen, P.; Lu, Y. VSTH: A User-Friendly Web Server for Structure-Based Virtual Screening on Tianhe-2. Bioinformatics 2023, 39, btac740. [Google Scholar] [CrossRef] [PubMed]
  193. Kochnev, Y.; Hellemann, E.; Cassidy, K.C.; Durrant, J.D. Webina: An Open-Source Library and Web App That Runs AutoDock Vina Entirely in the Web Browser. Bioinformatics 2020, 36, 4513–4515. [Google Scholar] [CrossRef]
  194. Pierce, B.G.; Wiehe, K.; Hwang, H.; Kim, B.-H.; Vreven, T.; Weng, Z. ZDOCK Server: Interactive Docking Prediction of Protein-Protein Complexes and Symmetric Multimers. Bioinformatics 2014, 30, 1771–1773. [Google Scholar] [CrossRef]
  195. Forli, S.; Huey, R.; Pique, M.E.; Sanner, M.F.; Goodsell, D.S.; Olson, A.J. Computational Protein-Ligand Docking and Virtual Drug Screening with the AutoDock Suite. Nat. Protoc. 2016, 11, 905–919. [Google Scholar] [CrossRef]
  196. Macip, G.; Garcia-Segura, P.; Mestres-Truyol, J.; Saldivar-Espinoza, B.; Ojeda-Montes, M.J.; Gimeno, A.; Cereto-Massagué, A.; Garcia-Vallvé, S.; Pujadas, G. Haste Makes Waste: A Critical Review of Docking-Based Virtual Screening in Drug Repurposing for SARS-CoV-2 Main Protease (M-pro) Inhibition. Med. Res. Rev. 2022, 42, 744–769. [Google Scholar] [CrossRef]
  197. Caballero, J. The Latest Automated Docking Technologies for Novel Drug Discovery. Expert Opin. Drug Discov. 2021, 16, 625–645. [Google Scholar] [CrossRef]
  198. McNutt, A.T.; Li, Y.; Meli, R.; Aggarwal, R.; Koes, D.R. GNINA 1.3: The next Increment in Molecular Docking with Deep Learning. J. Cheminform. 2025, 17, 28. [Google Scholar] [CrossRef]
  199. Valdés-Tresanco, M.S.; Valdés-Tresanco, M.E.; Valiente, P.A.; Moreno, E. Gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS. J. Chem. Theory Comput. 2021, 17, 6281–6291. [Google Scholar] [CrossRef] [PubMed]
  200. Ylilauri, M.; Pentikäinen, O.T. MMGBSA As a Tool To Understand the Binding Affinities of Filamin–Peptide Interactions. J. Chem. Inf. Model. 2013, 53, 2626–2633. [Google Scholar] [CrossRef] [PubMed]
  201. Miller, B.R.; McGee, T.D.; Swails, J.M.; Homeyer, N.; Gohlke, H.; Roitberg, A.E. MMPBSA.Py: An Efficient Program for End-State Free Energy Calculations. J. Chem. Theory Comput. 2012, 8, 3314–3321. [Google Scholar] [CrossRef]
  202. Azam, F.; Bello, M. Microsecond MD Simulations to Explore the Structural and Energetic Differences between the Human RXRα-PPARγ vs. RXRα-PPARγ-DNA. Molecules 2022, 27, 5778. [Google Scholar] [CrossRef]
  203. Azam, F.; Bello, M. Dynamic and Thermodynamic Impact of L94A, W100A, and W100L Mutations on the D2 Dopamine Receptor Bound to Risperidone. RSC Adv. 2022, 12, 34359–34368. [Google Scholar] [CrossRef]
  204. Genheden, S.; Ryde, U. The MM/PBSA and MM/GBSA Methods to Estimate Ligand-Binding Affinities. Expert Opin. Drug Discov. 2015, 10, 449–461. [Google Scholar] [CrossRef]
  205. Morehead, A.; Giri, N.; Liu, J.; Neupane, P.; Cheng, J. Assessing the Potential of Deep Learning for Protein–Ligand Docking. Nat. Mach. Intell. 2026, 8, 32–41. [Google Scholar] [CrossRef]
  206. Pantsar, T.; Poso, A. Binding Affinity via Docking: Fact and Fiction. Molecules 2018, 23, 1899. [Google Scholar] [CrossRef]
  207. Guedes, I.A.; Pereira, F.S.S.; Dardenne, L.E. Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and Challenges. Front. Pharmacol. 2018, 9, 1089. [Google Scholar] [CrossRef] [PubMed]
  208. Li, Y.; Han, L.; Liu, Z.; Wang, R. Comparative Assessment of Scoring Functions on an Updated Benchmark: 2. Evaluation Methods and General Results. J. Chem. Inf. Model. 2014, 54, 1717–1736. [Google Scholar] [CrossRef]
  209. Warren, G.L.; Andrews, C.W.; Capelli, A.-M.; Clarke, B.; LaLonde, J.; Lambert, M.H.; Lindvall, M.; Nevins, N.; Semus, S.F.; Senger, S.; et al. A Critical Assessment of Docking Programs and Scoring Functions. J. Med. Chem. 2006, 49, 5912–5931. [Google Scholar] [CrossRef] [PubMed]
  210. Rueda, M.; Bottegoni, G.; Abagyan, R. Consistent Improvement of Cross-Docking Results Using Binding Site Ensembles Generated with Elastic Network Normal Modes. J. Chem. Inf. Model. 2009, 49, 716–725. [Google Scholar] [CrossRef] [PubMed]
  211. Chen, Y.-C. Beware of Docking! Trends Pharmacol. Sci. 2015, 36, 78–95, Erratum in Trends Pharmacol. Sci. 2015, 36, 617. [Google Scholar] [CrossRef] [PubMed]
  212. Bender, B.J.; Gahbauer, S.; Luttens, A.; Lyu, J.; Webb, C.M.; Stein, R.M.; Fink, E.A.; Balius, T.E.; Carlsson, J.; Irwin, J.J.; et al. A Practical Guide to Large-Scale Docking. Nat. Protoc. 2021, 16, 4799–4832, Correction in Nat. Protoc. 2022, 17, 177. https://doi.org/10.1038/s41596-021-00650-x. [Google Scholar] [CrossRef]
  213. Zhu, H.; Zhang, Y.; Li, W.; Huang, N. A Comprehensive Survey of Prospective Structure-Based Virtual Screening for Early Drug Discovery in the Past Fifteen Years. Int. J. Mol. Sci. 2022, 23, 15961. [Google Scholar] [CrossRef]
  214. Jiang, Y.; Li, X.; Zhang, Y.; Han, J.; Xu, Y.; Pandit, A.; ZHANG, Z.; Wang, M.; Wang, M.; Liu, C.; et al. PoseX: {AI} Defeats Physics-Based Methods on Protein Ligand Cross-Docking. In Proceedings of the Fourteenth International Conference on Learning Representations, Rio de Janeiro, Brazil, 23–27 April 2026. [Google Scholar]
  215. Pak, M.A.; Frolova, D.; Sergei, N.; Daulbaev, T.; Ryabchenko, D.; Litvin, A.; Gurevich, P.; Garifullin, K.; Shapeev, A.; Oseledets, I.; et al. Bento: Benchmarking Classical and AI Docking on Drug Design—Relevant Data. bioRxiv 2026. [Google Scholar] [CrossRef]
  216. Peng, C.; Ni, W.; Liu, Q.; Hu, G.; Zheng, W. A Comprehensive Benchmarking of the AlphaFold3 for Predicting Biomacromolecules and Their Interactions. Brief. Bioinform. 2025, 26, bbaf616. [Google Scholar] [CrossRef]
  217. Krishna, R.; Wang, J.; Ahern, W.; Sturmfels, P.; Venkatesh, P.; Kalvet, I.; Lee, G.R.; Morey-Burrows, F.S.; Anishchenko, I.; Humphreys, I.R.; et al. Generalized Biomolecular Modeling and Design with RoseTTAFold All-Atom. Science 2026, 384, eadl2528. [Google Scholar] [CrossRef]
  218. Wohlwend, J.; Corso, G.; Passaro, S.; Getz, N.; Reveiz, M.; Leidal, K.; Swiderski, W.; Atkinson, L.; Portnoi, T.; Chinn, I.; et al. Boltz-1: Democratizing Biomolecular Interaction Modeling. bioRxiv 2024. [Google Scholar] [CrossRef]
  219. Gorgulla, C. Recent Developments in Ultralarge and Structure-Based Virtual Screening Approaches. Annu. Rev. Biomed. Data Sci. 2023, 6, 229–258. [Google Scholar] [CrossRef]
  220. Tingle, B.I.; Irwin, J.J. Large-Scale Docking in the Cloud. J. Chem. Inf. Model. 2023, 63, 2735–2741. [Google Scholar] [CrossRef] [PubMed]
  221. Lyu, J.; Wang, S.; Balius, T.E.; Singh, I.; Levit, A.; Moroz, Y.S.; O’Meara, M.J.; Che, T.; Algaa, E.; Tolmachova, K.; et al. Ultra-Large Library Docking for Discovering New Chemotypes. Nature 2019, 566, 224–229. [Google Scholar] [CrossRef] [PubMed]
  222. Malkov, Y.A.; Yashunin, D.A. Efficient and Robust Approximate Nearest Neighbor Search Using Hierarchical Navigable Small World Graphs. IEEE Trans. Pattern Anal. Mach. Intell. 2020, 42, 824–836. [Google Scholar] [CrossRef] [PubMed]
  223. Heid, E.; Greenman, K.P.; Chung, Y.; Li, S.-C.; Graff, D.E.; Vermeire, F.H.; Wu, H.; Green, W.H.; McGill, C.J. Chemprop: A Machine Learning Package for Chemical Property Prediction. J. Chem. Inf. Model. 2024, 64, 9–17. [Google Scholar] [CrossRef]
  224. Seebeck, B.; Reulecke, I.; Kämper, A.; Rarey, M. Modeling of Metal Interaction Geometries for Protein-Ligand Docking. Proteins 2008, 71, 1237–1254. [Google Scholar] [CrossRef] [PubMed]
  225. Santos-Martins, D.; Forli, S.; Ramos, M.J.; Olson, A.J. AutoDock4(Zn): An Improved AutoDock Force Field for Small-Molecule Docking to Zinc Metalloproteins. J. Chem. Inf. Model. 2014, 54, 2371–2379. [Google Scholar] [CrossRef]
  226. Adeniyi, A.A.; Soliman, M.E.S. Implementing QM in Docking Calculations: Is It a Waste of Computational Time? Drug Discov. Today 2017, 22, 1216–1223. [Google Scholar] [CrossRef]
  227. Cai, H.; Shen, C.; Jian, T.; Zhang, X.; Chen, T.; Han, X.; Yang, Z.; Dang, W.; Hsieh, C.-Y.; Kang, Y.; et al. CarsiDock: A Deep Learning Paradigm for Accurate Protein–Ligand Docking and Screening Based on Large-Scale Pre-Training. Chem. Sci. 2024, 15, 1449–1471. [Google Scholar] [CrossRef]
  228. Gentile, F.; Agrawal, V.; Hsing, M.; Ton, A.-T.; Ban, F.; Norinder, U.; Gleave, M.E.; Cherkasov, A. Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery. ACS Cent. Sci. 2020, 6, 939–949. [Google Scholar] [CrossRef] [PubMed]
  229. Yan, J.; Zhang, Z.; Zhu, J.; Zhang, K.; Pei, J.; Liu, Q. Deltadock: A Unified Framework for Accurate, Efficient, and Physically Reliable Molecular Docking. Adv. Neural Inf. Process. Syst. 2024, 37, 113282–113310. [Google Scholar]
  230. Zhu, J.; Gu, Z.; Pei, J.; Lai, L. DiffBindFR: An SE(3) Equivariant Network for Flexible Protein–Ligand Docking. Chem. Sci. 2024, 15, 7926–7942. [Google Scholar] [CrossRef]
  231. Corso, G.; Stärk, H.; Jing, B.; Barzilay, R.; Jaakkola, T. Diffdock: Diffusion Steps, Twists, and Turns for Molecular Docking. arXiv 2022, arXiv:2210.01776. [Google Scholar]
  232. Lu, W.; Zhang, J.; Huang, W.; Zhang, Z.; Jia, X.; Wang, Z.; Shi, L.; Li, C.; Wolynes, P.G.; Zheng, S. DynamicBind: Predicting Ligand-Specific Protein-Ligand Complex Structure with a Deep Equivariant Generative Model. Nat. Commun. 2024, 15, 1071. [Google Scholar] [CrossRef] [PubMed]
  233. Wu, H.; Liu, W.; Bian, Y.; Wu, J.; Yang, N.; Yan, J. EBMDock: Neural Probabilistic Protein-Protein Docking via a Differentiable Energy Model. In Proceedings of the Twelfth International Conference on Learning Representations, Vienna, Austria, 7–11 May 2024. [Google Scholar]
  234. Stärk, H.; Ganea, O.; Pattanaik, L.; Barzilay, R.; Jaakkola, T. Equibind: Geometric Deep Learning for Drug Binding Structure Prediction. In Proceedings of the International Conference on Machine Learning, PMLR, Baltimore, MA, USA, 17–23 July 2022; pp. 20503–20521. [Google Scholar]
  235. Pei, Q.; Gao, K.; Wu, L.; Zhu, J.; Xia, Y.; Xie, S.; Qin, T.; He, K.; Liu, T.-Y.; Yan, R. Fabind: Fast and Accurate Protein-Ligand Binding. Adv. Neural Inf. Process. Syst. 2023, 36, 55963–55980. [Google Scholar]
  236. Morehead, A.; Cheng, J. FlowDock: Geometric Flow Matching for Generative Protein–Ligand Docking and Affinity Prediction. Bioinformatics 2025, 41, i198–i206. [Google Scholar] [CrossRef] [PubMed]
  237. McNutt, A.T.; Francoeur, P.; Aggarwal, R.; Masuda, T.; Meli, R.; Ragoza, M.; Sunseri, J.; Koes, D.R. GNINA 1.0: Molecular Docking with Deep Learning. J. Cheminform. 2021, 13, 43. [Google Scholar] [CrossRef] [PubMed]
  238. Zhang, X.; Zhang, O.; Shen, C.; Qu, W.; Chen, S.; Cao, H.; Kang, Y.; Wang, Z.; Wang, E.; Zhang, J.; et al. Efficient and Accurate Large Library Ligand Docking with KarmaDock. Nat. Comput. Sci. 2023, 3, 789–804. [Google Scholar] [CrossRef] [PubMed]
  239. Qiao, Z.; Nie, W.; Vahdat, A.; Miller, T.F., III; Anandkumar, A. State-Specific Protein–Ligand Complex Structure Prediction with a Multiscale Deep Generative Model. Nat. Mach. Intell. 2024, 6, 195–208. [Google Scholar] [CrossRef]
  240. McNutt, A.T.; Koes, D.R. Open-ComBind: Harnessing Unlabeled Data for Improved Binding Pose Prediction. J. Comput. Aided Mol. Des. 2023, 38, 3. [Google Scholar] [CrossRef]
  241. The OpenFold3 Team. OpenFold3-preview; Version 0.4.0; Zenodo: Geneva, Switzerland, 2025. [Google Scholar] [CrossRef]
  242. Gentile, F.; Yaacoub, J.C.; Gleave, J.; Fernandez, M.; Ton, A.-T.; Ban, F.; Stern, A.; Cherkasov, A. Artificial Intelligence–Enabled Virtual Screening of Ultra-Large Chemical Libraries with Deep Docking. Nat. Protoc. 2022, 17, 672–697. [Google Scholar] [CrossRef]
  243. Cremer, J.; Le, T.; Noé, F.; Clevert, D.-A.; Schütt, K.T. PILOT: Equivariant Diffusion for Pocket-Conditioned de Novo Ligand Generation with Multi-Objective Guidance via Importance Sampling. Chem. Sci. 2024, 15, 14954–14967. [Google Scholar] [CrossRef]
  244. Peng, X.; Luo, S.; Guan, J.; Xie, Q.; Peng, J.; Ma, J. Pocket2Mol: Efficient Molecular Sampling Based on 3D Protein Pockets. In Proceedings of the International Conference on Machine Learning, Baltimore, MA, USA, 17–23 July 2022. [Google Scholar]
  245. Du, J.; Yuan, M.; Shen, A.; Wang, M. PPDock: Pocket Prediction-Based Protein–Ligand Blind Docking. J. Chem. Inf. Model. 2025, 65, 554–562. [Google Scholar] [CrossRef]
  246. Shen, C.; Zhang, X.; Deng, Y.; Gao, J.; Wang, D.; Xu, L.; Pan, P.; Hou, T.; Kang, Y. Boosting Protein-Ligand Binding Pose Prediction and Virtual Screening Based on Residue-Atom Distance Likelihood Potential and Graph Transformer. J. Med. Chem. 2022, 65, 10691–10706. [Google Scholar] [CrossRef]
  247. Xu, Z.; Wauchope, O.R.; Frank, A.T. Navigating Chemical Space by Interfacing Generative Artificial Intelligence and Molecular Docking. J. Chem. Inf. Model. 2021, 61, 5589–5600. [Google Scholar] [CrossRef]
  248. Cao, D.; Chen, M.; Zhang, R.; Wang, Z.; Huang, M.; Yu, J.; Jiang, X.; Fan, Z.; Zhang, W.; Zhou, H.; et al. SurfDock Is a Surface-Informed Diffusion Generative Model for Reliable and Accurate Protein–Ligand Complex Prediction. Nat. Methods 2025, 22, 310–322. [Google Scholar] [CrossRef]
  249. Lu, W.; Wu, Q.; Zhang, J.; Rao, J.; Li, C.; Zheng, S. TANKBind: Trigonometry-Aware Neural NetworKs for Drug-Protein Binding Structure Prediction. In Proceedings of the Advances in Neural Information Processing Systems; Koyejo, S., Mohamed, S., Agarwal, A., Belgrave, D., Cho, K., Oh, A., Eds.; Curran Associates, Inc.: New York, NY, USA, 2022; Volume 35, pp. 7236–7249. [Google Scholar]
  250. Guan, J.; Qian, W.W.; Peng, X.; Su, Y.; Peng, J.; Ma, J. 3D Equivariant Diffusion for Target-Aware Molecule Generation and Affinity Prediction. In Proceedings of the International Conference on Learning Representations, Kigali, Rwanda, 1–5 May 2023. [Google Scholar]
  251. Zhou, G.; Gao, Z.; Ding, Q.; Zheng, H.; Xu, H.; Wei, Z.; Zhang, L.; Ke, G. Uni-Mol: A Universal 3D Molecular Representation Learning Framework. In Proceedings of the Eleventh International Conference on Learning Representations, Kigali, Rwanda, 1–5 May 2023. [Google Scholar]
  252. Ragoza, M.; Hochuli, J.; Idrobo, E.; Sunseri, J.; Koes, D.R. Protein–Ligand Scoring with Convolutional Neural Networks. J. Chem. Inf. Model. 2017, 57, 942–957. [Google Scholar] [CrossRef]
  253. Sunseri, J.; Koes, D.R. Virtual Screening with Gnina 1.0. Molecules 2021, 26, 7369. [Google Scholar] [CrossRef]
  254. Cormack, G.V.; Clarke, C.L.A.; Buettcher, S. Reciprocal Rank Fusion Outperforms Condorcet and Individual Rank Learning Methods. In Proceedings of the 32nd International ACM SIGIR Conference on Research and Development in Information Retrieval; Association for Computing Machinery: New York, NY, USA, 2009; pp. 758–759. [Google Scholar]
  255. Jiang, J.; Li, D.; Wang, G.; Wei, G.-W. Recent Advances in Machine Learning Predictions of Protein-Ligand Binding Affinities. Curr. Opin. Struct. Biol. 2026, 96, 103193. [Google Scholar] [CrossRef]
  256. Bajusz, D.; Rácz, A.; Héberger, K. Comparison of Data Fusion Methods as Consensus Scores for Ensemble Docking. Molecules 2019, 24, 2690. [Google Scholar] [CrossRef]
  257. Khandelwal, A.; Lukacova, V.; Comez, D.; Kroll, D.M.; Raha, S.; Balaz, S. A Combination of Docking, QM/MM Methods, and MD Simulation for Binding Affinity Estimation of Metalloprotein Ligands. J. Med. Chem. 2005, 48, 5437–5447. [Google Scholar] [CrossRef]
  258. Wang, K. GPDOCK: Highly Accurate Docking Strategy for Metalloproteins Based on Geometric Probability. Brief. Bioinform. 2023, 24, bbac620. [Google Scholar] [CrossRef] [PubMed]
  259. Tsaban, T.; Varga, J.K.; Avraham, O.; Ben-Aharon, Z.; Khramushin, A.; Schueler-Furman, O. Harnessing Protein Folding Neural Networks for Peptide–Protein Docking. Nat. Commun. 2022, 13, 176. [Google Scholar] [CrossRef] [PubMed]
  260. Xu, S.; Feng, Q.; Qiao, L.; Wu, H.; Shen, T.; Cheng, Y.; Zheng, S.; Sun, S. Benchmarking All-Atom Biomolecular Structure Prediction with FoldBench. Nat. Commun. 2025, 17, 442. [Google Scholar] [CrossRef] [PubMed]
  261. Martis, E.A.F.; Téletchéa, S. Ten Quick Tips to Perform Meaningful and Reproducible Molecular Docking Calculations. PLoS Comput. Biol. 2025, 21, e1013030. [Google Scholar] [CrossRef]
  262. Aci-Sèche, S.; Bourg, S.; Bonnet, P.; Rebehmed, J.; de Brevern, A.G.; Diharce, J. A Perspective on the Sharing of Docking Data. Data Br. 2023, 49, 109386. [Google Scholar] [CrossRef]
  263. Mirgaux, M.; Barcelli, V.; Chua, A.C.Y.; Bifani, P.; Wintjens, R. AI-Guided Competitive Docking for Virtual Screening and Compound Efficacy Prediction. npj Drug Discov. 2026, 3, 6. [Google Scholar] [CrossRef]
  264. Irwin, J.J.; Shoichet, B.K.; Mysinger, M.M.; Huang, N.; Colizzi, F.; Wassam, P.; Cao, Y. Automated Docking Screens: A Feasibility Study. J. Med. Chem. 2009, 52, 5712–5720. [Google Scholar] [CrossRef]
  265. Li, L.; Chen, R.; Weng, Z. RDOCK: Refinement of Rigid-Body Protein Docking Predictions. Proteins 2003, 53, 693–707. [Google Scholar] [CrossRef] [PubMed]
  266. Morley, S.D.; Afshar, M. Validation of an Empirical RNA-Ligand Scoring Function for Fast Flexible Docking Using RiboDock®. J. Comput. Aided Mol. Des. 2004, 18, 189–208. [Google Scholar] [CrossRef] [PubMed]
  267. Li, C.; Wang, Y.; Xing, H.; Wang, Y.; Wang, Y.; Ye, J. Vina-CUDA: An Efficient Program with in-Depth Utilization of GPU to Accelerate Molecular Docking. J. Chem. Inf. Model. 2025, 65, 4751–4759. [Google Scholar] [CrossRef] [PubMed]
Figure 1. A conceptual map of molecular docking classification, encompassing flexibility, search scope, target and ligand types, interaction chemistry, and subsequent applications in structure-based workflows.
Figure 1. A conceptual map of molecular docking classification, encompassing flexibility, search scope, target and ligand types, interaction chemistry, and subsequent applications in structure-based workflows.
Ijms 27 03302 g001
Figure 2. Rationale for open-source molecular docking tools.
Figure 2. Rationale for open-source molecular docking tools.
Ijms 27 03302 g002
Figure 3. Sunburst chart summarizing representative open-source and commercial tools, with segment sizes proportional to Google Scholar citation counts as of 8 March 2026. Citation counts and their corresponding percentages are reported in parentheses. These counts are intended only as a rough proxy for historical visibility and community adoption and should not be interpreted as a direct measure of methodological superiority, predictive accuracy, or current practical performance.
Figure 3. Sunburst chart summarizing representative open-source and commercial tools, with segment sizes proportional to Google Scholar citation counts as of 8 March 2026. Citation counts and their corresponding percentages are reported in parentheses. These counts are intended only as a rough proxy for historical visibility and community adoption and should not be interpreted as a direct measure of methodological superiority, predictive accuracy, or current practical performance.
Ijms 27 03302 g003
Figure 4. Decision workflow for selecting an appropriate docking strategy based on target class, membrane versus soluble protein, binding-site location ligand class, sampling requirements, receptor flexibility, and post-docking validation.
Figure 4. Decision workflow for selecting an appropriate docking strategy based on target class, membrane versus soluble protein, binding-site location ligand class, sampling requirements, receptor flexibility, and post-docking validation.
Ijms 27 03302 g004
Figure 5. Decision workflow for AI-augmented structure-based drug design, beginning with structural availability, branching through AI-based structure generation when holo complexes are unavailable, and ending with target-class-specific docking and physical validity assessment.
Figure 5. Decision workflow for AI-augmented structure-based drug design, beginning with structural availability, branching through AI-based structure generation when holo complexes are unavailable, and ending with target-class-specific docking and physical validity assessment.
Ijms 27 03302 g005
Figure 6. Tiered AI-augmented screening pipeline integrating chemical-space navigation, high-throughput physics-based docking, AI rescoring or affinity prediction, consensus ranking, and final validity and interaction-level inspection.
Figure 6. Tiered AI-augmented screening pipeline integrating chemical-space navigation, high-throughput physics-based docking, AI rescoring or affinity prediction, consensus ranking, and final validity and interaction-level inspection.
Ijms 27 03302 g006
Table 1. Representative prospective hit-discovery studies using free or academically accessible docking/SBDD workflows.
Table 1. Representative prospective hit-discovery studies using free or academically accessible docking/SBDD workflows.
SNStudyTargetWorkflowTested/Hit RateBest Potency/Validation
1Cabeza de Vaca et al. 2026 [48]GPR139Docking 235 million compounds to the GPR139 binding site68 top-ranked compounds tested; 5 full agonists (7.4%)Potencies ranged from 160 nM to 3.6 µM; optimized compounds showed in vivo behavioral effects; cryo-EM confirmed the predicted binding mode
2Tummino et al. 2025 [49]CB1 receptorDocking 74 million tangible molecules against human CB1 receptor46 tested; 9 active by radioligand competition (19.6%)Optimization yielded ‘1350, a Ki 0.95 nM full agonist; analgesic activity at 0.05 mg/kg; cryo-EM confirmed the pose
3Zhou et al. 2024 [44]KLHDC2; NaV1.7RosettaVS AI-accelerated virtual screening of multi-billion librariesKLHDC2: 7 hits (14%); NaV1.7: 4 hits (44%)All hits were single-digit µM; X-ray validated the KLHDC2 docking pose
4Díaz-Holguín et al. 2024 [50]TAAR1AlphaFold-guided docking of >16 million compounds, compared with a homology model screenAF2 screen: 30 tested; 18 agonists (60%); homology model: 32 tested; 7 agonists (22%)Agonists ranged from 12 to 0.03 µM; one lead showed antipsychotic-like effects in wild-type but not TAAR1-knockout mice
5Liu et al. 2024 [52]Calcium-sensing receptor (CaSR)Large-library docking of 2.7 million and 1.2 billion molecules against CaSR2.7 M screen: 13.6% hit rate; 1.2 B screen: 36.5% hit rateDocking produced hits up to 37-fold more potent; optimization yielded nanomolar leads, and one lead lowered serum parathyroid hormone in mice
6Lyu et al. 2024 [43]σ2 receptor; 5-HT2A receptorDOCK3.8 prospective docking against AlphaFold2 models versus experimental structures; >490 million (σ2) and 1.6 billion (5-HT2A) moleculesσ2: AF2 55% vs. experimental 51% at 1 µM; 5-HT2A: AF2 26% vs. experimental 23% at 10 µMσ2 AF2 hits had Ki 1.6–84 nM; 5-HT2A AF2 agonists had EC50 42 nM–1.6 µM; cryo-EM of Z7757 supported the docking pose
7Luttens et al. 2025 [51]OGG1Docking of 14 million fragment-like molecules and 235 million lead-like molecules against OGG129 top-ranked compounds tested; 4 binders (13.8%)X-ray crystallography confirmed docking poses; fragment elaboration yielded submicromolar inhibitors with cellular anti-inflammatory and anticancer effects
8Gahbauer et al. 2023 [47]EP4RDocked 440 million compounds against an EP4R using DOCK3.771 top-ranked compounds tested; 6 (8.5%) dose-dependent antagonistsBest initial hit had IC50 850 nM; optimization reached Ki 16 nM
9Kaplan et al. 2022 [46]5-HT2A receptorDOCK-based screening of 75 million tetrahydropyridines against a receptor model17 tested; 4 initial low-µM actives (23.5%)(R)-69 and (R)-70 reached EC50 41 nM and 110 nM; cryo-EM confirmed the predicted binding mode
10Everson et al. 2021 [53]Plasmodium falciparum HSP90AutoDock/Smina screening of 13 million ZINC15 compounds12 tested; 3 active compounds (25.0%)Best hit had EC50 0.98 µM
11Stein et al. 2020 [45]MT1 melatonin receptorDocking >150 million virtual molecules against an MT1 crystal structure38 synthesized/tested; 15 active (39%)Ligands ranged from 470 pM to 6 µM; selective MT1 inverse agonists showed in vivo circadian effects in mice
Abbreviations: AF2 = AlphaFold2; CB1 = cannabinoid-1; EC50 = half-maximal effective concentration; EP4R = prostaglandin E2 receptor 4; GPR139 = G protein-coupled receptor 139; IC50 = half-maximal inhibitory concentration; Ki = inhibition constant; TAAR1 = trace amine-associated receptor 1; OGG1 = 8-oxoguanine DNA glycosylase; CaSR = calcium-sensing receptor.
Table 3. Open-source installable software for docking and structure-based drug design (SBDD).
Table 3. Open-source installable software for docking and structure-based drug design (SBDD).
SNToolsStagePrimary FunctionTypical ApplicationReference/Official Link
1AMDockGraphical docking assistantGUI workflow for AutoDock4/Vina plus preparation helpersGuided preparation, box definition, docking[128] https://github.com/Valdes-Tresanco-MS/AMDock
2ATTRACTMacromolecular docking suiteCoarse-grained rigid-body/flexible dockingMacromolecular docking and refinement[129,130] https://github.com/sjdv1982/attract
3AutoDock CrankPep (ADCP)Peptide docking engineMonte Carlo peptide folding + AutoDock affinity gridsPeptide docking[131] https://github.com/ccsb-scripps/ADCP
4AutoDock VinaGeneral-purpose small-molecule docking engineGradient-based local optimization + Vina/Vinardo/AD4 scoring supportRoutine docking and virtual screening[18,132] https://github.com/ccsb-scripps/AutoDock-Vina
5AutoDock4Classical small-molecule docking engineLamarckian genetic algorithm + empirical free-energy scoringDocking/redocking/VS baseline[85] https://github.com/ccsb-scripps/AutoDock4
6AutoDockFR (ADFR)Flexible-receptor dockingGenetic algorithm with explicitly specified receptor flexibilityFlexible-side-chain docking[133,134] https://ccsb.scripps.edu/adfr/
7AutoDock-GPUAccelerated AutoDock4 implementationGPU/OpenCL/CUDA/SYCL acceleration of AutoDock4 searchLarge-scale VS on accelerators[135] https://github.com/ccsb-scripps/AutoDock-GPU
8DOCK 6Classical docking suiteSphere matching/anchor-and-grow/GA/grid scoring optionsDocking, de novo design, rescoring[136] https://dock.compbio.ucsf.edu/DOCK_6/index.htm
9DockeyIntegrated docking GUI/workbenchPipeline integrating preparation, docking, interaction detection, visualizationLarge-scale docking and vs. from GUI[137] https://github.com/lmdu/dockey
10DockingPieConsensus docking PyMOL pluginGUI integration of Vina, smina, ADFR, RxDockConsensus docking and result analysis[138] https://github.com/paiardin/DockingPie
11DockoMaticHTVS GUI managerAutoDock job creation/management automationBatch job setup and management[139,140,141] https://sourceforge.net/projects/dockomatic/
12FlexAIDFlexible docking engine, NRGsuite PyMOL pluginGenetic algorithm + soft surface complementarity scoringFlexible docking, non-native receptor cases[142] https://github.com/NRGlab/FlexAID
13HADDOCK3Integrative biomolecular docking platformInformation-driven docking with restraints and modular workflowsIntegrative docking with prior data[120] https://github.com/haddocking/haddock3
14IdockMultithreaded docking toolVina-inspired search optimized for speedFast virtual screening[143] https://github.com/gloglita/idock
15LeDockSmall-molecule docking engineFast flexible docking with empirical scoringRapid protein–ligand docking and VShttps://www.lephar.com/software
16LightDockMacromolecular docking frameworkGlowworm Swarm Optimization (GSO)Protein–protein docking[144,145] https://github.com/lightdock/lightdock
17MetalDockMetal-complex docking toolPython workflow for docking metal-organic compoundsDock organometallic compounds to proteins/DNA/biomolecules[146] https://github.com/MatthijsHak/MetalDock
18MzDOCKAutomated GUI based pipeline for Molecular DockingIntegrates docking, ligand preparation, visualization, and post-docking analysis in a single GUI environmentProtein-ligand docking and post-docking analysis[147] https://github.com/Muzatheking12/MzDOCK
19OpenDockExtensible docking frameworkTraditional + machine-learning scoring functions in a PyTorch frameworkMethod development, docking, rescoring[60] https://github.com/guyuehuo/opendock
20pydock3Automation/wrapper for DOCK3 pipelinePython orchestration around UCSF DOCKAutomated DOCK3 campaigns, parameter optimization[148] https://github.com/docking-org/pydock3
21PyRxGUI virtual screening workbenchFront-end around AutoDock/Vina and preparation utilitiesTeaching, small/medium screening campaigns[149] https://pyrx.sourceforge.io/
22QuickVina 2Fast Vina derivativeHeuristic acceleration of Vina searchRapid docking/scrseening[150] https://github.com/QVina/qvina
23QuickVina-WBlind-docking-oriented Vina derivativeQVina2 acceleration + thread communication for wider boxesBlind docking in wide search spaces[71] https://qvina.github.io/
24rDockHTVS-oriented docking engineStochastic search with cavity maps and scoring for proteins/nucleic acidsHTVS and binding-mode prediction[151] https://github.com/CBDD/rDock
25SEEDFragment docking programForce-field/solvation-based exhaustive fragment dockingFragment docking and fragment-based screening[152] https://gitlab.com/CaflischLab/SEED
26sminaVina fork for scoring/minimizationVina-based search with custom scoring supportCustom scoring-function development and minimization[153] https://github.com/mwojcikowski/smina
27Uni-DockGPU-accelerated docking engineGPU implementation supporting vina/vinardo/ad4 scoringUltra-fast virtual screening[154] https://github.com/dptech-corp/Uni-Dock
28Vina-CarbSpecialized Vina derivativeVina modified for carbohydrate torsional preferencesGlycoligand docking[155] https://github.com/Alicecomma/VinaCarb
29Vina-GPUGPU-accelerated Vina derivativeLarge-scale docking accelerationSpeedups for Vina workflows[156,157,158] https://github.com/DeltaGroupNJUPT/Vina-GPU-2.1
30VinaXBSpecialized Vina derivativeVina with explicit halogen-bond scoring termHalogen-sensitive docking[159] https://github.com/sirimullalab/vinaXB
Table 4. Open-source webservers for docking and structure-based drug design (SBDD).
Table 4. Open-source webservers for docking and structure-based drug design (SBDD).
SNToolsStagePrimary FunctionTypical ApplicationReference/Official Link
1CABS-dockFlexible peptide dockingBinding-site search with fully flexible peptide dockingPeptide docking without prior site knowledge[160] https://biocomp.chem.uw.edu.pl/CABSdock
2CB-Dock2Blind-docking serverAutomatic cavity detection + docking + homologous template fittingVery accessible blind docking[20] https://cadd.labshare.cn/cb-dock2/
3ClusProProtein–protein dockingFFT-based global sampling with clustering-driven model selectionAccessible macromolecular docking and clustering-based ranking[161] https://cluspro.org/
4DINC-EnsembleEnsemble dockingIncremental docking of large ligands against receptor conformationsLarge-ligand docking and ensemble docking[132,162,163] https://dinc-ensemble.kavrakilab.rice.edu/
5DockThor/DockThor-VSDocking and VSDockThor engine with web-based submissionDocking and virtual screening[42,164] https://dockthor.lncc.br/v2/
6EDockProtein–ligand dockingBased on replica-exchange Monte Carlo simulations for blind dockingDocking[165] https://aideepmed.com/EDock/
7GalaxyWEBMulti-tool docking/modeling suiteStructure prediction, refinement, docking, target predictionProtein–ligand, protein–peptide, and protein–protein docking; Compound target prediction; Covalent ligand docking[166,167,168,169,170,171,172,173,174,175] https://galaxy.seoklab.org/
8GRAMM WebMacromolecular dockingFree-docking and template-based docking modes for protein complexesProtein–protein docking[176] https://gramm.compbio.ku.edu/gramm
9HADDOCK web portalIntegrative docking portalHADDOCK workflows via web portalRestraint-driven online docking[177,178] https://alcazar.science.uu.nl/
10HawkDockProtein–protein docking and rerankingATTRACT-based sampling with HawkRank and MM/GBSA rerankingProtein–protein docking and ranking[179] https://cadd.zju.edu.cn/hawkdock/
11HDOCKHybrid templateTemplate-based modeling + ab initio dockingMacromolecular docking[180,181,182] http://hdock.phys.hust.edu.cn/
12HPEPDOCKBlind peptide dockingHierarchical protein–peptide docking algorithmProtein–peptide docking[183] http://huanglab.phys.hust.edu.cn/hpepdock/
13MolModaBrowser-based docking environmentWeb-based end-to-end molecular docking workflowInteractive preparation, docking, and visualization[184] https://github.com/durrantlab/molmoda
14MTiAutoDock/MTiOpenScreenDocking + screeningAutoDock-based site-specific/blind docking and virtual screeningDocking and library screening[185] https://bioserv.rpbs.univ-paris-diderot.fr/services/MTiOpenScreen/
15NPDockProtein–nucleic acid dockingGRAMM-based global docking plus scoring, clustering, and refinementRNA–protein and DNA–protein docking[123] https://genesilico.pl/NPDock/
16ProteinsPlusProtein-structure analysis and structure-based molecular designIntegrated protein-structure analysis and drug-design platform with tools for docking, binding-site analysis, protonation, visualization, and structural profilingProtein structure analysis, binding-site/druggability assessment, and automated protein-ligand docking[186] https://proteins.plus/
17pyDockDNAProtein–DNA dockingEnergy-based pyDockDNA scoring/workflowProtein–DNA complex modeling[187] https://model3dbio.csic.es/pydockdna/
18pyDockWEBProtein–protein dockingFTDock sampling + pyDock scoringRigid-body macromolecular docking[188] https://life.bsc.es/pid/pydockweb
19ROSIEMulti-step SBDD platformRosetta-based modeling and dockingProtein docking, Protein–ligand docking, Peptide docking/refinement[189,190] https://rosie.graylab.jhu.edu/
20SeamDockCollaborative online dockingCommon web framework wrapping several docking toolsTeaching/collaborative docking[41,191] https://bioserv.rpbs.univ-paris-diderot.fr/services/SeamDock/
21SwissDockProtein–small-molecule dockingCurrent server supports attracting-cavities and AutoDock Vina enginesDocking[5,21] https://www.swissdock.ch/
22VSTH (MatGen Virtual Screening)Integrated structure-based virtual-screening platformProtein preparation, pocket selection, docking (AutoDock Vina, AutoDock4, GalaxyDock3, iDock, iGemdock, and LeDock), monitoring, and analysisEnd-to-end structure-based virtual screening[192] https://matgen.nscc-gz.cn/VirtualScreening.html
23WebinaDockingBrowser-based AutoDock Vina dockingDocking[193] https://github.com/durrantlab/webina
24ZDOCKProtein docking serverAutomatic rigid-body protein dockingProtein–protein docking[194] https://zdock.wenglab.org/
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Azam, F.; Almahmoud, S.A. Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities. Int. J. Mol. Sci. 2026, 27, 3302. https://doi.org/10.3390/ijms27073302

AMA Style

Azam F, Almahmoud SA. Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities. International Journal of Molecular Sciences. 2026; 27(7):3302. https://doi.org/10.3390/ijms27073302

Chicago/Turabian Style

Azam, Faizul, and Suliman A. Almahmoud. 2026. "Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities" International Journal of Molecular Sciences 27, no. 7: 3302. https://doi.org/10.3390/ijms27073302

APA Style

Azam, F., & Almahmoud, S. A. (2026). Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities. International Journal of Molecular Sciences, 27(7), 3302. https://doi.org/10.3390/ijms27073302

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop